DGE	Genes	Process~name	num_of_Genes	gene_group	percentage%	P-value	Benjamini and Hochberg (FDR)	 Hommel singlewise process	Bonferroni single-step process	Hommel singlewise process	Hochberg step-up process	Benjamini and Yekutieli
up	PSMB11; NFATC1; IGKV1D-16; IGKV1-5; IGKV3-20; IGKV3-15; IGLV1-47; IGLV1-40; IGLV2-14; IGLV2-23; IGLV2-11; IGLV2-8; IGLV3-19; IGLV3-1; IGHV1-46; IGHV3-23; IGHV3-13; IGHV3-30; IGHV3-7; IGHV2-5; IGHV4-39; IGKC; IGHE; IGLV7-43; IGKV1-16; IGKV3-11; IGKV2-30; IGKV4-1; IGHV4-34; LYN; IGLC2; IGLC3; IGHV1-2; PSMA2; PSMB8; PSMB9; FCER1G; PSMB10; PSMB3; MAPK10; LILRA4; GRB2; IGLV3-21; PSME1; PSMA8; PSMF1; LAT2; PSME2;	GO:0038095~Fc-epsilon receptor signaling pathway	48	171	28.0701754385965	0.00010972330225789	0.0324329172850532	0.549604021009778	0.551359593845904	0.54949429770752	0.549604021009778	0.295123197763604
down	SRRM4; NRG2; GJB1; NTF3; PTN; DLX5; VLDLR; PCDH1; SIM2; CNTN4; FGF14; ATOH8; LINC01587; NDN; NRTN; SDCBP2; PCDHA4; PCDHB4; PCDHB11; ERBB3; GFRA3; NAV2; TYRO3; ROR1; RBFOX2;	GO:0007399~nervous system development	25	294	8.50340136054422	0.00011364294090743	0.00468558587126029	0.416160449603018	0.426388314284686	0.343315324481353	0.416160449603018	0.0412677972875321
down	ALOX12B; GSTA1; ALOX12; CYP2J2; ALOXE3; ALOX15B;	GO:0043651~linoleic acid metabolic process	6	18	33.3333333333333	0.00012254822816548	0.00494409625889146	0.448526515085681	0.459800952076906	0.357763930929765	0.448526515085681	0.0435445999257932
down	RAMP2; CDH5; OCLN; MARVELD2; PARD3; POF1B; CRB3; PARD6G;	GO:0070830~bicellular tight junction assembly	8	38	21.0526315789474	0.00014634230726184	0.00564277157207257	0.535320159963842	0.549076336846456	0.396294968065086	0.535320159963842	0.0496981081500285
down	HPGD; FOXF1; TFAP2B; STRA6;	GO:0097070~ductus arteriosus closure	4	5	80	0.00014701394705307	0.00564277157207257	0.5376300043731	0.551596329343142	0.397378698884465	0.537482990426047	0.0496981081500285
down	GJB5; GJB1; GJA1; GJB2;	GO:1905867~epididymis development	4	5	80	0.00014701394705307	0.00564277157207257	0.5376300043731	0.551596329343142	0.397378698884465	0.537482990426047	0.0496981081500285
down	EGFL8; TFAP2B; ROR1; NR2F6; HNF4A; HNF4G; TFAP2C; SPARCL1; TFAP2A;	GO:0048856~anatomical structure development	9	50	18	0.00016311287913783	0.00611999522525172	0.595851347490525	0.611999522525172	0.421646792571314	0.595851347490525	0.0539012045228873
up	HP; HPR; IGKV1D-16; IGKV1-5; IGKV3-20; IGKV3-15; IGLV1-47; IGLV1-40; IGLV2-14; IGLV2-23; IGLV2-11; IGLV2-8; IGLV3-19; IGLV3-1; IGHV1-46; IGHV3-23; IGHV3-13; IGHV3-30; IGHV3-7; IGHV2-5; IGHV4-39; IGKC; APOE; IGLV7-43; IGKV1-16; IGKV3-11; ITGB2; IGKV2-30; IGKV4-1; IGHV4-34; ASGR1; CD14; IGLC2; IGLC3; FOLR2; IGHV1-2; MASP1; PPT1; HBA1; IGLV3-21; SNX17; LDLRAP1; FCGR1B; COLEC11; CXCL16;	GO:0006898~receptor-mediated endocytosis	45	160	28.125	0.00016978485089491	0.0473982708748308	0.850282533281741	0.853168875746954	0.849942963579951	0.850282533281741	0.43130037135118
down	OVOL1; FOXP2; SOX15; FOXH1; DKK1; SPDEF; IL33; TFAP2A; GLI2; NR2F6; SCGB1A1; BMP2; HOXD8; EFNA1; CCND1; HOXD9; HOXA7; HOXC8; HNF1B; SOX18; MMP12; FOXA1; FOXF1; KLF5; TRIM29; SIM2; CRYM; HES5; MLIP; NRARP; WWC1; BCL6B; SDR16C5; ZNF366; TFAP2B; TFAP2C; FOXJ1; OVOL2; IRX2; FOXQ1; PEG3; WWTR1; TP63; MYOZ1; TFCP2L1; HEY2; NOTCH3; BARX2; ID1; HES2; NR0B2; ID4;	GO:0000122~negative regulation of transcription by RNA polymerase II	52	847	6.13931523022432	0.00018074302782777	0.00652065231163295	0.659531308543565	0.678147840409826	0.443143296219333	0.659531308543565	0.057429949033581
down	PHGDH; APOD; CD9; ID1; SLC6A11; STAR; ITGA8; HPCA; SHROOM2; HES5; CNTN4; CTTNBP2; FOXJ1; SLC38A3; SLC6A17; ROBO2; ABCB6; CDH22; NDRG4; ADGRL2;	GO:0007420~brain development	20	217	9.21658986175115	0.00020056228420195	0.00716675895548319	0.731651212768732	0.752509690325735	0.465141415032564	0.731651212768732	0.0631204643153697
down	GABRQ; GABRB2; HTR3B; CHRNB4; GABRA3; GABRR1; GABRE; GABRG1; GABRA4;	GO:0050877~nervous system process	9	52	17.3076923076923	0.00021181541352977	0.00749746633550658	0.772490813143071	0.794731431563697	0.477643757509632	0.772490813143071	0.0660331342557512
down	NCKAP5; SORBS2; MSMB; TM4SF1; CRYBA2; XG; KRTDAP; TCHH; RAD51AP2; FAM189A2; KRT24; EXOC3L2; PRICKLE4; TTC39A; GGT6; SBSN; KRT27; TMPRSS11B; UNC93A; IL22RA1; FIBIN; NKX2-3; GIPC2; TMEM54; TMEM125; KIF12; CYYR1; DEPDC7; GPR87; GSDMC; UACA; RNF39; EPB41L4A; CCM2L; ETNK2; CGN; FETUB; PSORS1C2; PCDHGB5; LINC01558;	GO:0008150~biological_process	40	603	6.6334991708126	0.0002288782945552	0.00802571365580482	0.834490261948265	0.858751361171116	0.496190124482993	0.834490261948265	0.0706856161290343
down	GJA1; GJA4; KDR; GJA5;	GO:0003158~endothelium development	4	6	66.6666666666667	0.00023840198755631	0.00820627759001183	0.868975244642763	0.894484257311289	0.504640235384653	0.868736842655207	0.0722759137009982
down	ALOX15B; ALOX12B; ALOX12; ALOXE3;	GO:0051122~hepoxilin biosynthetic process	4	6	66.6666666666667	0.00023840198755631	0.00820627759001183	0.868975244642763	0.894484257311289	0.504640235384653	0.868736842655207	0.0722759137009982
down	SMPD2; ALOX12B; FA2H; CERS3; SPTSSB; ALOXE3; DEGS2;	GO:0046513~ceramide biosynthetic process	7	31	22.5806451612903	0.0002618287423024	0.00893074037380569	0.953842108207664	0.982381441118626	0.52495031502141	0.953842108207664	0.0786565423193625
down	GABRB2; GABRA4; GABRG1; GABRA3; GABRE;	GO:0051932~synaptic transmission, GABAergic	5	13	38.4615384615385	0.00026883498092167	0.00900597186087604	0.979097000516732	1	0.530423231759971	0.978828165535811	0.0793191356093716
down	CYP1A1; CPS1; HNF1B; HNF4A; ANXA1;	GO:0070365~hepatocyte differentiation	5	13	38.4615384615385	0.00026883498092167	0.00900597186087604	0.979097000516732	1	0.530423231759971	0.978828165535811	0.0793191356093716
down	BMP2; HEY2; WNT3; WNT7B; WNT9B; WNT2B; WNT4; WNT9A; WNT5A;	GO:0045165~cell fate commitment	9	55	16.3636363636364	0.00030705785476192	0.0100197905016469	1	1	0.560119871387734	0.999999737396233	0.0882482350439321
down	TJP1; CNN3; MYH14; EPB41L4B; LIMCH1; FRMD6; EPB41L4A;	GO:0031032~actomyosin structure organization	7	32	21.875	0.00030978030335582	0.0100197905016469	1	1	0.56212404309612	0.999999737396233	0.0882482350439321
down	FGF1; ADRA2A; ADRA2C; NTF3; WNT5A; IL18; DYNAP;	GO:0032148~activation of protein kinase B activity	7	32	21.875	0.00030978030335582	0.0100197905016469	1	1	0.56212404309612	0.999999737396233	0.0882482350439321
down	UGT1A9; UGT1A6; UGT1A1; UGT1A7; UGT1A10;	GO:0052695~cellular glucuronidation	5	14	35.7142857142857	0.00035463578122241	0.0110882787595541	1	1	0.592241754641428	0.999999737396233	0.0976588312944198
down	SCNN1A; SCNN1B; SCNN1G; TFAP2B; CYP4F12;	GO:0055078~sodium ion homeostasis	5	14	35.7142857142857	0.00035463578122241	0.0110882787595541	1	1	0.592241754641428	0.999999737396233	0.0976588312944198
down	CYP1A1; TH; STAR; LCN2;	GO:0009635~response to herbicide	4	7	57.1428571428571	0.00036452010936882	0.0112510924319929	1	1	0.598128550323666	0.999999737396233	0.0990927953310318
down	ZBTB7C; SULT2B1; WNT9A; TAX1BP3; ALOX15B; GJB6; HRAS; TFF1; TFAP2A; BCHE; BMP2; NME1; CD9; NPPC; CDH5; HNF4A; CDKN2B; SLURP1; DPT; DDR1; FGFBP1; GPNMB; DHCR24; BNIPL; TFAP2B; FRZB; RERG; NDN; SOX7;	GO:0008285~negative regulation of cell population proliferation	29	396	7.32323232323232	0.00036584042556053	0.0112510924319929	1	1	0.5988807766426	0.999999737396233	0.0990927953310318
down	PPL; SMPD2; SCEL; CCNB1; IGFBP2; BDKRB1; ENDOG; LRP11; PIEZO2;	GO:0009612~response to mechanical stimulus	9	57	15.7894736842105	0.00038835616592569	0.0117509059238162	1	1	0.612049317498897	0.999999737396233	0.103494849295863
down	CYP1A1; GLI2; BMP2; CCNB1; FOXF1; KLF5; IL18; PLA2G4F;	GO:0071407~cellular response to organic cyclic compound	8	45	17.7777777777778	0.00040270518208396	0.0120875987454322	1	1	0.619763275227218	0.999999737396233	0.106460235374014
down	PLA2G10; PLA2G2A; BDKRB2; PLA2G4F; PLA2G3; ANXA1;	GO:0050482~arachidonic acid secretion	6	24	25	0.00045392815860889	0.0134727586639485	1	1	0.644577985224632	0.999999737396233	0.118659883464717
down	GJB6; CXCL14; C1QB; BMP2; GJB2; HPCA; ROR1; CYTL1;	GO:0048839~inner ear development	8	46	17.3913043478261	0.00045875898423364	0.0134727586639485	1	1	0.646881618780843	0.999999737396233	0.118659883464717
down	CTSV; SEMA3F; NRTN; NTF4; NTF3;	GO:0021675~nerve development	5	15	33.3333333333333	0.00045962502904728	0.0134727586639485	1	1	0.647359878645668	0.999999737396233	0.118659883464717
down	MAOA; COMT; MAOB; PRIMA1;	GO:0042135~neurotransmitter catabolic process	4	8	50	0.00053203989874017	0.0152382725196423	1	1	0.676989081005333	0.999999737396233	0.134209458247241
down	CYP1A1; MAOB; DUOX2; DUOX1;	GO:0050665~hydrogen peroxide biosynthetic process	4	8	50	0.00053203989874017	0.0152382725196423	1	1	0.676989081005333	0.999999737396233	0.134209458247241
down	AQP1; SCNN1A; SCNN1B; SCNN1G;	GO:0050891~multicellular organismal water homeostasis	4	8	50	0.00053203989874017	0.0152382725196423	1	1	0.676989081005333	0.999999737396233	0.134209458247241
down	MT1X; MT1A; MT1H; MT1M; MT1G;	GO:0010273~detoxification of copper ion	5	16	31.25	0.00058640356662476	0.0164192998654933	1	1	0.694975832152615	0.999999737396233	0.144611230499149
down	CSTA; CSTB; SERPINB3; SERPINB4; ECM1;	GO:0010466~negative regulation of peptidase activity	5	16	31.25	0.00058640356662476	0.0164192998654933	1	1	0.694975832152615	0.999999737396233	0.144611230499149
down	PLA2G10; PLA2G2A; PLA2G4E; PLA2G4F; PLA2G4D; PLA2G3;	GO:0036152~phosphatidylethanolamine acyl-chain remodeling	6	26	23.0769230769231	0.00065366323960192	0.0181669961110104	1	1	0.716101530800116	0.999999737396233	0.160003878582404
down	AGR2; PTN; FOXF1; VWC2; EGFLAM; NPNT; EGFL6;	GO:0010811~positive regulation of cell-substrate adhesion	7	37	18.9189189189189	0.00066561668271947	0.0182364360822237	1	1	0.719692162859267	0.999999737396233	0.160615463714855
down	KLK8; SNCG; NFASC; C1QA; WNT7B; PCDHGC3; PCDHGC5; PCDHGC4;	GO:0050808~synapse organization	8	49	16.3265306122449	0.00066588266078482	0.0182364360822237	1	1	0.719819156308393	0.999999737396233	0.160615463714855
down	SFN; KDF1; TP63;	GO:0010482~regulation of epidermal cell division	3	3	100	0.00072904354733971	0.0195205414706888	1	1	0.739149438418164	0.999999737396233	0.171925084821585
down	TMEM79; DUOX2; DUOX1;	GO:0042335~cuticle development	3	3	100	0.00072904354733971	0.0195205414706888	1	1	0.739149438418164	0.999999737396233	0.171925084821585
down	KRT6A; KRT16; SERPINB5; RIPK4; CA9;	GO:0002009~morphogenesis of an epithelium	5	17	29.4117647058824	0.00073769236309007	0.0195205414706888	1	1	0.741686705030443	0.999999737396233	0.171925084821585
down	ALOX15B; PLA2G10; PLA2G2A; AGTR1; IL18;	GO:0010744~positive regulation of macrophage derived foam cell differentiation	5	17	29.4117647058824	0.00073769236309007	0.0195205414706888	1	1	0.741686705030443	0.999999737396233	0.171925084821585
down	CYP1A1; TH; GGT5; PLA2G4D; ACOT11; MECR; UGT1A8; CYP4F11; FA2H;	GO:0006631~fatty acid metabolic process	9	63	14.2857142857143	0.00074445372366582	0.0195327997985607	1	1	0.743709269942162	0.999999737396233	0.172033048735513
down	CH25H; STAR; ACOX2; HSD3B7; CYP39A1; AMACR;	GO:0006699~bile acid biosynthetic process	6	27	22.2222222222222	0.00077607241639099	0.0195424409818725	1	1	0.753503948082939	0.999999737396233	0.172117962428156
down	GABRR1; GABRB2; GABRG1; GABRA4; GABRA3; GABRE;	GO:0007214~gamma-aminobutyric acid signaling pathway	6	27	22.2222222222222	0.00077607241639099	0.0195424409818725	1	1	0.753503948082939	0.999999737396233	0.172117962428156
down	GFRA3; NFASC; ERBB3; UGT8; NTF3; NTF4;	GO:0007422~peripheral nervous system development	6	27	22.2222222222222	0.00077607241639099	0.0195424409818725	1	1	0.753503948082939	0.999999737396233	0.172117962428156
down	PLA2G10; PLA2G2A; PLA2G4E; PLA2G4F; PLA2G4D; PLA2G3;	GO:0036151~phosphatidylcholine acyl-chain remodeling	6	27	22.2222222222222	0.00077607241639099	0.0195424409818725	1	1	0.753503948082939	0.999999737396233	0.172117962428156
down	CDH5; CDH19; CDH3; CDH17; CDH1; CDH8;	GO:0044331~cell-cell adhesion mediated by cadherin	6	27	22.2222222222222	0.00077607241639099	0.0195424409818725	1	1	0.753503948082939	0.999999737396233	0.172117962428156
down	COBL; CYP1A1; CCNB1; CLDN18; FOXF1; LGR4;	GO:0048565~digestive tract development	6	28	21.4285714285714	0.00091544096861662	0.0226186226333511	1	1	0.792629015331641	0.999999737396233	0.199211103883847
down	PLA2G10; PLA2G2A; PLA2G4F; PLA2G4D; PLA2G3;	GO:0036148~phosphatidylglycerol acyl-chain remodeling	5	18	27.7777777777778	0.00091631946702275	0.0226186226333511	1	1	0.792629015331641	0.999999737396233	0.199211103883847
down	BMP2; BMP7; WNT5A; WNT4; FOXF2; AKNAD1; FAM83D;	GO:0001837~epithelial to mesenchymal transition	7	40	17.5	0.00099978821890178	0.0242013251439968	1	1	0.814827398404956	0.999999737396233	0.213150587263377
down	TULP1; PIGR; TF; HSPB1; CDH3; PRDX1; ZG16B;	GO:0001895~retina homeostasis	7	40	17.5	0.00099978821890178	0.0242013251439968	1	1	0.814827398404956	0.999999737396233	0.213150587263377
up	BNIP3L; ABCC9; IFNA21; IFNA5; IFNB1; IFNG; IFI6; RNASE2; IRF1; PRF1; IRF2; AZU1; CD40; PML; APOBEC3A; IFNAR2; DEFA3; IRF9; BST2; IRF5; IRF3; IFI16; AGBL4; UNC13D; NLRP9; APOBEC3F; LILRB1; IRF7; RNASE6; ISG20; RTP4; TRIM11; POLR3C; TRIM34; NT5C3A; UNC93B1; CARD9; IL21; APOBEC3G; MOV10; EXOSC5; TLR8; TLR7; PYCARD; POLR3K; IFITM1; IFITM2; TLR9; APOBEC3C;	GO:0051607~defense response to virus	49	198	24.7474747474747	0.00104982584076041	0.249511541364776	1	1	0.999999994869077	0.999999994869077	1
down	CXCL11; CXCL10; APLNR; BDKRB1; CX3CL1; CXCL9;	GO:0051281~positive regulation of release of sequestered calcium ion into cytosol	6	29	20.6896551724138	0.00107328943505836	0.0252698696878333	1	1	0.833613894920812	0.999999737396233	0.222561679246178
down	PLA2G10; PLA2G2A; PLA2G4E; PLA2G4F; PLA2G4D;	GO:0036149~phosphatidylinositol acyl-chain remodeling	5	19	26.3157894736842	0.00112520663517202	0.0262222068022696	1	1	0.844322749678922	0.999999737396233	0.230949286701845
up	TNIP2; TLR9; IGHV3-16; IGHV3-49; IGLC3; IGHV4-39; IGHV3-21; IGHD; IGHV3-23; IGHV3-13; IGHV1-2; TRBC1; IGHV1-18; IGLL5; TRBC2; IGHE; IGLC2; IGHV1-46; IGHV5-51; IGHV1-3; IGHV6-1; IGHV4-34; IGHV3-7; TRDC; IGKC; IGHV3-35; IGHV3-30; IGHV3-43; IGHV2-5;	GO:0050871~positive regulation of B cell activation	29	98	29.5918367346939	0.0011745065605544	0.249511541364776	1	1	0.999999994869077	0.999999994869077	1
up	SASH3; CD4; HLA-DPB1; CD3E; CD1D; VCAM1; HLA-DPA1; HLA-DMB; CD40LG; CD6; CORO1A; CD70; AIF1; NCKAP1L; CD276; CLECL1; LILRB2; IL21; PDCD1LG2; CD80; CD86;	GO:0042102~positive regulation of T cell proliferation	21	61	34.4262295081967	0.00118028084248389	0.249511541364776	1	1	0.999999994869077	0.999999994869077	1
down	KCNK1; KCNK5; AQP1; GJA5; KCNJ5; FXYD3; KCNJ8; KCNS3; KCNK7;	GO:0006813~potassium ion transport	9	68	13.2352941176471	0.00121294523496207	0.0280924106270228	1	1	0.861196663393727	0.999999737396233	0.247420907209255
down	SOX18; OVOL2; SOX17;	GO:0060214~endocardium formation	3	4	75	0.00124347019773374	0.0284481718408354	1	1	0.865409230620664	0.999999737396233	0.250554236115771
down	ANXA8; PLA2R1; ANXA1;	GO:1900138~negative regulation of phospholipase A2 activity	3	4	75	0.00124347019773374	0.0284481718408354	1	1	0.865409230620664	0.999999737396233	0.250554236115771
up	TRAV19; PSMB11; CD4; TRBV12-3; TRAV8-4; TRAC; TRBC1; HLA-DRA; HLA-DQA1; HLA-DRB1; THY1; CD3D; TRBV7-9; TRAV29DV5; HLA-A; HLA-DPB1; LCK; CD3E; CD3G; HLA-DPA1; CD247; GATA3; PSMA2; PSMB8; PSMB9; PSMB10; PSMB3; PSME1; RFTN1; HLA-DRB5; TRAT1; SKAP1; NFKBID; PSMA8; PSMF1; RBCK1; FOXP3; PSME2; CD276; BTN2A2; HHLA2; CTLA4; BTN1A1; BTNL8;	GO:0050852~T cell receptor signaling pathway	44	174	25.2873563218391	0.00127917289651536	0.257113752199587	1	1	0.999999994869077	0.999999994869077	1
down	TSPAN15; BMP7; DLK2; NRARP; CHAC1; HEY2; NOTCH3;	GO:0045746~negative regulation of Notch signaling pathway	7	42	16.6666666666667	0.00128736001884155	0.0290974384981537	1	1	0.871077422420522	0.999999737396233	0.25627258287879
down	ALOX15B; BRINP1; INHA; BMP2; HPGD; BMP7; ADCYAP1;	GO:0045786~negative regulation of cell cycle	7	42	16.6666666666667	0.00128736001884155	0.0290974384981537	1	1	0.871077422420522	0.999999737396233	0.25627258287879
down	FUT1; FUT3; FUT2; FUT6;	GO:0036065~fucosylation	4	11	36.3636363636364	0.00135192850602006	0.0301783463327172	1	1	0.879505128649258	0.999999737396233	0.265792563224657
down	EDN3; EDN2; HRC; NMU; HEY2;	GO:0010460~positive regulation of heart rate	5	20	25	0.00136735577733527	0.0301783463327172	1	1	0.881571064417392	0.999999737396233	0.265792563224657
down	GJA1; ALOX12; ADCYAP1; NPPC; GJA5;	GO:0097755~positive regulation of blood vessel diameter	5	20	25	0.00136735577733527	0.0301783463327172	1	1	0.881571064417392	0.999999737396233	0.265792563224657
down	GLI2; HOXB1; SOSTDC1; GRHL3; SHROOM3; FOXJ1;	GO:0007389~pattern specification process	6	31	19.3548387096774	0.00145077152470674	0.0312322004698318	1	1	0.89200647638727	0.999999737396233	0.27507427101873
down	NRG2; ERBB3; BTC; PTK6; GRB7; PTPRR;	GO:0038128~ERBB2 signaling pathway	6	31	19.3548387096774	0.00145077152470674	0.0312322004698318	1	1	0.89200647638727	0.999999737396233	0.27507427101873
down	SCGB1A1; IDO1; GPNMB; IL20RB; VTCN1; FOXJ1; PLA2G2A;	GO:0042130~negative regulation of T cell proliferation	7	43	16.2790697674419	0.00145347375826144	0.0312322004698318	1	1	0.892366132643861	0.999999737396233	0.27507427101873
down	CXCL11; CXCL10; CX3CL1; ACKR1; CCL21; CCL11; CXCL9; CCL17; CCL19;	GO:0070098~chemokine-mediated signaling pathway	9	70	12.8571428571429	0.00145672576818245	0.0312322004698318	1	1	0.892727253895387	0.999999737396233	0.27507427101873
up	PSMB11; TNFRSF13B; TNFSF12; ST18; TNFSF13; LTA; TNF; TNFRSF1A; TNFRSF1B; PSMA2; CD40; CD27; PSMB8; PSMB9; TNFRSF8; CD40LG; CD70; PSMB10; TNFRSF4; PSMB3; TNFRSF17; PSME1; LTB; TNFRSF9; TRADD; COMMD7; PSMA8; PSMF1; TNFRSF14; CDIP1; PSME2; PYCARD; TNFRSF18;	GO:0033209~tumor necrosis factor-mediated signaling pathway	33	120	27.5	0.00158125413915455	0.294288964787097	1	1	0.999999994869077	0.999999994869077	1
down	PLPP2; PLA2G2A; PLA2G4E; TNFAIP8L3; PLA2G4F; PLA2G4D; PLA2G3; GDPD3;	GO:0006644~phospholipid metabolic process	8	57	14.0350877192982	0.00160113238324655	0.0337497118086576	1	1	0.909444362886052	0.999999737396233	0.297246983344197
down	DLX3; GLI2; BMP2; BMP7; AMTN; SOSTDC1; NKX2-3; TP63;	GO:0042475~odontogenesis of dentin-containing tooth	8	57	14.0350877192982	0.00160113238324655	0.0337497118086576	1	1	0.909444362886052	0.999999737396233	0.297246983344197
down	CLEC3B; BMP2; PTN; FGFR3; GPNMB; LGR4; TUFT1;	GO:0030282~bone mineralization	7	44	15.9090909090909	0.00163583007692236	0.0339295285945471	1	1	0.913675211260897	0.999999737396233	0.298830700487126
down	PLA2G10; PLA2G2A; PLA2G4E; PLA2G4F; PLA2G4D;	GO:0036150~phosphatidylserine acyl-chain remodeling	5	21	23.8095238095238	0.00164583534227281	0.0339295285945471	1	1	0.914982051897865	0.999999737396233	0.298830700487126
down	SRPX2; ANXA1; KDR; FGFBP1; PLK2;	GO:0090050~positive regulation of cell migration involved in sprouting angiogenesis	5	21	23.8095238095238	0.00164583534227281	0.0339295285945471	1	1	0.914982051897865	0.999999737396233	0.298830700487126
down	SLC6A15; SLC6A17; SLC6A14; SLC6A1; SLC6A11; TMEM184A;	GO:0006810~transport	6	32	18.75	0.00167369829649067	0.0341074241898084	1	1	0.918101932245688	0.999999737396233	0.30039749694872
down	KCNK5; SCNN1B; SCNN1G; AMN; UGT1A7; ATP6V0A4;	GO:0007588~excretion	6	32	18.75	0.00167369829649067	0.0341074241898084	1	1	0.918101932245688	0.999999737396233	0.30039749694872
down	CTSG; CPA3; CMA1; ACE2;	GO:0002003~angiotensin maturation	4	12	33.3333333333333	0.00175421443128243	0.0348244050061994	1	1	0.927600042319852	0.999999737396233	0.306712228938023
down	ALDH7A1; CRYM; AADAT; SLC25A21;	GO:0006554~lysine catabolic process	4	12	33.3333333333333	0.00175421443128243	0.0348244050061994	1	1	0.927600042319852	0.999999737396233	0.306712228938023
down	CHST9; DIO2; DUOX2; DUOX1;	GO:0042446~hormone biosynthetic process	4	12	33.3333333333333	0.00175421443128243	0.0348244050061994	1	1	0.927600042319852	0.999999737396233	0.306712228938023
down	RAMP2; CEACAM1; KDR; TMEM100;	GO:2001214~positive regulation of vasculogenesis	4	12	33.3333333333333	0.00175421443128243	0.0348244050061994	1	1	0.927600042319852	0.999999737396233	0.306712228938023
down	CCL21; CXCL11; DEFB4A; GPR37; RGS5; GPR39; GALR2; RAMP2; RAMP3; RGS11; ADGRL2; CXCL10; ANXA1; CCK; ADRA2A; EDN3; PDE6A; ADCYAP1; ADRA2C; EDN2; NPY1R; BDKRB2; AGTR1; PTGER1; APLNR; ADCYAP1R1; GPR1; BDKRB1; NMU; AKR1C2; PDE1A; DEFB1; GNAI1; CX3CL1; CXCL9; ACKR1; FFAR4; ADGRF1; ARHGEF16; RGS7BP; PREX2; ARHGEF25; ADGRF4; ADGRF2; NGEF; OR2I1P; QRFPR; CCL19; GPR62; ADGRL4; ARHGEF4; LPAR3; FZD10; GNG4; CCL11; CGB7; GPR87; MRGPRX3; GPR78; GNG12; CCL17;	GO:0007186~G protein-coupled receptor signaling pathway	61	1152	5.29513888888889	0.00184097487603252	0.0363544091309159	1	1	0.937518679404932	0.999999737396233	0.320187576910017
down	EPHB3; TYRO3; DDR1; KDR; ROR1; ERBB3; EPHA2; MST1R; FGFR3;	GO:0033674~positive regulation of kinase activity	9	73	12.3287671232877	0.00189469781907581	0.0369331067841487	1	1	0.943712019618433	0.999999737396233	0.325284394704108
down	ADCYAP1; IL1RN; HNF1B; FAM3B; PCLO; ANXA1;	GO:0030073~insulin secretion	6	33	18.1818181818182	0.00192168338617105	0.0369331067841487	1	1	0.947242942303016	0.999999737396233	0.325284394704108
down	WNT9A; TFAP2A; HOXD9; CRABP2; WNT3; TP63;	GO:0035115~embryonic forelimb morphogenesis	6	33	18.1818181818182	0.00192168338617105	0.0369331067841487	1	1	0.947242942303016	0.999999737396233	0.325284394704108
down	SDC1; AQP1; AQP5; PAX9; AQP3; TUFT1;	GO:0042476~odontogenesis	6	33	18.1818181818182	0.00192168338617105	0.0369331067841487	1	1	0.947242942303016	0.999999737396233	0.325284394704108
down	NFASC; MAL; UGT8;	GO:0002175~protein localization to paranode region of axon	3	5	60	0.00193918497773915	0.0369331067841487	1	1	0.949051001908258	0.999999737396233	0.325284394704108
down	AQP1; RHBG; RHCG;	GO:0015696~ammonium transport	3	5	60	0.00193918497773915	0.0369331067841487	1	1	0.949051001908258	0.999999737396233	0.325284394704108
down	APOD; CCNB1; PTN; TM4SF4; KLK6;	GO:0042246~tissue regeneration	5	22	22.7272727272727	0.00196376675395571	0.0370253912605117	1	1	0.952129943989648	0.999999737396233	0.326097180376588
down	GSTA4; GSTA1; MGST1; GSTM3; GSTO2;	GO:1901687~glutathione derivative biosynthetic process	5	22	22.7272727272727	0.00196376675395571	0.0370253912605117	1	1	0.952129943989648	0.999999737396233	0.326097180376588
down	FOXH1; ELN; NPY1R; SOX18; GJA5; SOX17; HEY2;	GO:0003151~outflow tract morphogenesis	7	46	15.2173913043478	0.00205351466928827	0.0382748311853943	1	1	0.961605649005093	0.999999737396233	0.337101489114
down	WNT9B; DKK1; LRAT; GJA1; IGFBP2; GJB2; AQP3;	GO:0032526~response to retinoic acid	7	46	15.2173913043478	0.00205351466928827	0.0382748311853943	1	1	0.961605649005093	0.999999737396233	0.337101489114
down	EI24; ALOX15B; CIDEA; NOL3; GJB6; CEACAM5; CGB7; GJA1; MAL; KRT20; CEACAM6; LGALS7; FAM3B; ESPL1; DHCR24; ECSCR; PHLDA2; BNIPL; UNC5B; SLC5A8; CSRNP3; TFAP2B; CIDEC; NOX5; CARD14; PEG3; TP63; TP53AIP1; S100A14; PTPRH; PAK6; PAK5; TMEM14A; CASP14;	GO:0006915~apoptotic process	34	552	6.15942028985507	0.0020606385659514	0.0382748311853943	1	1	0.962318210299304	0.999999737396233	0.337101489114
down	HRAS; FGF1; ADRA2A; EDN3; MIF; MST1R; TPD52L1; EPGN;	GO:0043406~positive regulation of MAP kinase activity	8	60	13.3333333333333	0.00214419733251747	0.039436413684341	1	1	0.968762674134006	0.999999737396233	0.347332002952899
down	BMP2; BMP7; NPPC; WNT4; WNT7B; FFAR4; NPNT; TP63;	GO:0045669~positive regulation of osteoblast differentiation	8	60	13.3333333333333	0.00214419733251747	0.039436413684341	1	1	0.968762674134006	0.999999737396233	0.347332002952899
up	HLA-B; HLA-H; HLA-A; HLA-E; HLA-G; HLA-F; B2M;	GO:0002480~antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent	7	9	77.7777777777778	0.00216452719922211	0.388455327717539	1	1	0.999999994869077	0.999999994869077	1
down	OVOL1; GJB3; DHCR24; TFAP2B; ABCB6; DSP;	GO:0043588~skin development	6	34	17.6470588235294	0.00219647577603921	0.0400057141344617	1	1	0.972820852317035	0.999999737396233	0.352346055883907
down	CPZ; CPXM1; CPXM2; CPE;	GO:0006518~peptide metabolic process	4	13	30.7692307692308	0.00223250980107625	0.040465588278445	1	1	0.975360916888649	0.999999737396233	0.356396348306906
up	CXCR1; CXCR5; CCR2; CCR10; CXCR3; CCR3; CCR5; CCR6; CCR8; CMKLR1; GPR35; CCL2; PPBP; CCL4; CCL24; CXCL3; XCL2; CCL8; XCL1; CCL7; PF4V1; PF4;	GO:0070098~chemokine-mediated signaling pathway	22	70	31.4285714285714	0.00236731275984803	0.410198159249529	1	1	0.999999994869077	0.999999994869077	1
down	BCHE; TH; PTN; COMT; SLC6A1; STRA6; PAK6; PAK5;	GO:0007612~learning	8	62	12.9032258064516	0.00257999391225516	0.0460958912322922	1	1	0.991562999352608	0.999999737396233	0.405984640433173
down	SLC34A2; KRT19; IGFBP2; GSTM3; COMT; CCND1; STAR; ZNF366;	GO:0043627~response to estrogen	8	62	12.9032258064516	0.00257999391225516	0.0460958912322922	1	1	0.991562999352608	0.999999737396233	0.405984640433173
down	KLK8; GJA1; BMP7; WNT7B; UGT8; NYAP1; NTF3; NTF4;	GO:0048812~neuron projection morphogenesis	8	62	12.9032258064516	0.00257999391225516	0.0460958912322922	1	1	0.991562999352608	0.999999737396233	0.405984640433173
down	TAX1BP3; ADRA2A; AGTR1; EPS8L1; EPS8L2; RHOD; CDC42EP5; RHOV; RND3;	GO:0007266~Rho protein signal transduction	9	77	11.6883116883117	0.00263562317852428	0.0466576091669215	1	1	0.994122925799715	0.999999737396233	0.410931911168565
down	CYP1A1; CYP2E1; CYP2C9; HPGD; ALOX12;	GO:0042759~long-chain fatty acid biosynthetic process	5	24	20.8333333333333	0.00273065541927253	0.0466576091669215	1	1	0.998772751894414	0.999999737396233	0.410931911168565
down	CXCL14; CXCL10; IL18; SOSTDC1; CCL17;	GO:0045662~negative regulation of myoblast differentiation	5	24	20.8333333333333	0.00273065541927253	0.0466576091669215	1	1	0.998772751894414	0.999999737396233	0.410931911168565
down	CYP1A1; GJB2; ID1; SLC1A3; ENDOG;	GO:0046677~response to antibiotic	5	24	20.8333333333333	0.00273065541927253	0.0466576091669215	1	1	0.998772751894414	0.999999737396233	0.410931911168565
down	GLI2; WNT5A; MYO3A; GRHL3; FRZB;	GO:0090103~cochlea morphogenesis	5	24	20.8333333333333	0.00273065541927253	0.0466576091669215	1	1	0.998772751894414	0.999999737396233	0.410931911168565
up	ITGB2; FCER1G; ARHGAP25; AIF1; IGHV1-2; IGHV3-30; IGHE; IGLC2; IGHV3-7; IGHV3-43; IGHV3-21; IGHV2-5; TRDC; TRBC2; IGHV3-16; IGHV4-39; IGHV3-49; IGHV1-3; IGHV1-46; IGHV6-1; IGHV3-13; IGHV3-35; IGKC; IGHV4-34; IGLC3; IGHV5-51; IGHV1-18; IGHD; IGLL5; TRBC1; IGHV3-23;	GO:0006911~phagocytosis, engulfment	31	115	26.9565217391304	0.00277221263765903	0.464345616807888	1	1	0.999999994869077	0.999999994869077	1
down	GHR; FOXA1; WNT4; KLK6;	GO:0042445~hormone metabolic process	4	14	28.5714285714286	0.00279355974969886	0.0466576091669215	1	1	0.999999737396233	0.999999737396233	0.410931911168565
down	COBL; BMP7; PTN; VLDLR;	GO:1900006~positive regulation of dendrite development	4	14	28.5714285714286	0.00279355974969886	0.0466576091669215	1	1	0.999999737396233	0.999999737396233	0.410931911168565
down	DSP; GRHL1; PERP;	GO:0002934~desmosome organization	3	6	50	0.00283527049308585	0.0466576091669215	1	1	0.999999737396233	0.999999737396233	0.410931911168565
down	TH; CD9; LRP11;	GO:0009414~response to water deprivation	3	6	50	0.00283527049308585	0.0466576091669215	1	1	0.999999737396233	0.999999737396233	0.410931911168565
down	GJB6; GJA1; GJB2;	GO:0010644~cell communication by electrical coupling	3	6	50	0.00283527049308585	0.0466576091669215	1	1	0.999999737396233	0.999999737396233	0.410931911168565
down	CYP2E1; CYP2C9; CYP2C19;	GO:0016098~monoterpenoid metabolic process	3	6	50	0.00283527049308585	0.0466576091669215	1	1	0.999999737396233	0.999999737396233	0.410931911168565
down	SERPINB7; LUM; CX3CL1;	GO:0032914~positive regulation of transforming growth factor beta1 production	3	6	50	0.00283527049308585	0.0466576091669215	1	1	0.999999737396233	0.999999737396233	0.410931911168565
down	ALOX12; ALOX15B; ALOX12B;	GO:0034440~lipid oxidation	3	6	50	0.00283527049308585	0.0466576091669215	1	1	0.999999737396233	0.999999737396233	0.410931911168565
down	CYP2E1; UGT1A1; CYP2C19;	GO:0046483~heterocycle metabolic process	3	6	50	0.00283527049308585	0.0466576091669215	1	1	0.999999737396233	0.999999737396233	0.410931911168565
down	ID1; FOXF1; STRA6;	GO:0060426~lung vasculature development	3	6	50	0.00283527049308585	0.0466576091669215	1	1	0.999999737396233	0.999999737396233	0.410931911168565
down	DSP; TJP1; CGNL1;	GO:0150105~protein localization to cell-cell junction	3	6	50	0.00283527049308585	0.0466576091669215	1	1	0.999999737396233	0.999999737396233	0.410931911168565
down	GJB6; GJB2; GJB4;	GO:1990349~gap junction-mediated intercellular transport	3	6	50	0.00283527049308585	0.0466576091669215	1	1	0.999999737396233	0.999999737396233	0.410931911168565
down	OVOL1; KDF1; OVOL2;	GO:2000647~negative regulation of stem cell proliferation	3	6	50	0.00283527049308585	0.0466576091669215	1	1	0.999999737396233	0.999999737396233	0.410931911168565
up	CD74; CD19; CD27; PRKCD; TCIRG1; IRF7; TLR8; FCER1G;	GO:0016064~immunoglobulin mediated immune response	8	13	61.5384615384615	0.00300076990756593	0.486415122113509	1	1	0.999999994869077	0.999999994869077	1
down	PIGR; BTC; GRB7; FAM83B; EPGN; FAM83A; GAREM1;	GO:0007173~epidermal growth factor receptor signaling pathway	7	50	14	0.0031319132489771	0.0506545399400176	1	1	0.999999737396233	0.999999737396233	0.446134452205779
down	FOXP2; ELN; HOXD9; MEOX2; MYH14; VGLL2; MYOZ1;	GO:0007519~skeletal muscle tissue development	7	50	14	0.0031319132489771	0.0506545399400176	1	1	0.999999737396233	0.999999737396233	0.446134452205779
up	ACOD1; KCNN4; LILRA1; LILRB5; OR2H2; HP; CST3; HLA-B; CD74; CD48; GATA3; IL32; CAMLG; TAP1; CEBPE; LILRA2; IL31RA; RNASE6; CLEC1B; CD84; IRGM; STAT5A;	GO:0006952~defense response	22	72	30.5555555555556	0.00314759597720704	0.494270930795793	1	1	0.999999994869077	0.999999994869077	1
down	CTSV; GJA1; PTN; GJB2; STC1;	GO:0046697~decidualization	5	25	20	0.00318600087136489	0.0506545399400176	1	1	0.999999737396233	0.999999737396233	0.446134452205779
down	MT1A; MT1G; MT1H; MT1X; MT1M;	GO:0071294~cellular response to zinc ion	5	25	20	0.00318600087136489	0.0506545399400176	1	1	0.999999737396233	0.999999737396233	0.446134452205779
down	FOXN1; DKK1; HOXC13; SOX18; NSDHL; LGR4;	GO:0001942~hair follicle development	6	37	16.2162162162162	0.00319966043864184	0.0506545399400176	1	1	0.999999737396233	0.999999737396233	0.446134452205779
down	GLI2; BMP2; FGFR3; HES5; WNT2B; CYTL1;	GO:0002062~chondrocyte differentiation	6	37	16.2162162162162	0.00319966043864184	0.0506545399400176	1	1	0.999999737396233	0.999999737396233	0.446134452205779
down	CCL21; SOX18; HES5; ANGPTL8; CCL19; LHX6;	GO:0048469~cell maturation	6	37	16.2162162162162	0.00319966043864184	0.0506545399400176	1	1	0.999999737396233	0.999999737396233	0.446134452205779
down	NKX2-8; FGF1; GLI2; PTN; WNT5A; WNT7B; FOXF1; SIM2; STRA6;	GO:0030324~lung development	9	80	11.25	0.00332871397637369	0.0524761968040087	1	1	0.999999737396233	0.999999737396233	0.462178500539569
down	SOX18; GJA5; SOX17; NDRG4;	GO:0035050~embryonic heart tube development	4	15	26.6666666666667	0.00344393947462263	0.0531755592954078	1	1	0.999999737396233	0.999999737396233	0.46833806101259
down	ADCYAP1; ADCYAP1R1; FFAR4; GPR62;	GO:0043950~positive regulation of cAMP-mediated signaling	4	15	26.6666666666667	0.00344393947462263	0.0531755592954078	1	1	0.999999737396233	0.999999737396233	0.46833806101259
down	PLA2G4D; GDPD3; PLA2G4F; PLA2G4E;	GO:0046475~glycerophospholipid catabolic process	4	15	26.6666666666667	0.00344393947462263	0.0531755592954078	1	1	0.999999737396233	0.999999737396233	0.46833806101259
down	COBL; HRAS; EPS8L1; EPS8L2;	GO:1900029~positive regulation of ruffle assembly	4	15	26.6666666666667	0.00344393947462263	0.0531755592954078	1	1	0.999999737396233	0.999999737396233	0.46833806101259
down	PLA2G10; PLA2G2A; PLD1; LIPK; LIPI; ASPG; PLA2G3; PNLIPRP3; CES3;	GO:0016042~lipid catabolic process	9	81	11.1111111111111	0.00358908596246232	0.0549038489227024	1	1	0.999999737396233	0.999999737396233	0.483559787377869
down	MAP3K6; TF; WNT5A; WNT7B; ERN2; CCL19;	GO:0007257~activation of JUN kinase activity	6	38	15.7894736842105	0.00359977261060362	0.0549038489227024	1	1	0.999999737396233	0.999999737396233	0.483559787377869
up	OR2A1; GPR25; GPR31; P2RY10; FCN1; GNGT2; GPR171; RGS13; GNRH2; RGS14; RGS10; LGR5; OR6A2; UTS2; ADCY5; OR2H2; S1PR4; F2; KNG1; OXT; TSHB; CALCA; PTH; GHRH; APOE; PPBP; PF4; OPN1SW; GNAI2; PSAP; CD3E; RHOC; SCT; OR2T7; ADORA3; CALM2; CALCB; PTHLH; CCL4; RAC2; CXCL3; TRH; TBXA2R; HRH2; CXCR1; FPR3; F2R; PDE4A; PTPN6; AVPR2; AKT1; CCR7; GPR183; CXCR5; SSTR3; CNR2; TRHR; OPRM1; PTGER4; DRD3; GRK3; PDE6B; OPRD1; RGS2; VIPR2; CCR2; PTGER2; PTGIR; GLP1R; GRK6; CCR10; XCL1; CXCR3; GPR15; RGS19; RGS3; HTR6; CCR3; CCR5; CCR6; CCR8; NLRP6; TAS2R38; TAS2R39; TAS2R40; TAS2R41; TAS2R50; GNA12; RGS1; PTGDR; PNOC; ADGRE1; PDGFRL; GPR68; C3AR1; OR2B11; FGD3; PIK3R6; OR2T2; TAS2R42; OR2W3; VN1R5; GPR65; ADGRG5; OR2L13; OR2C3; PROKR2; OR2L5; OR2AK2; OR2L3; OR10G2; OR10AD1; OR52B6; OR2D3; OR56B2P; OR52N4; OR56B1; OR52H1; OR52K1; OR52I1; OR9A1P; OR9A4; GPR150; OR13D1; OR2T34; OR2L8; OR2T10; OR2T3; OR10AC1; OR2L2; OR52N5; OR52P1P; OR52I2; OR2AE1; GPBAR1; RXFP4; GPR151; RXFP2; RLN3; PIK3R5; KISS1R; GPR146; NPY6R; GPR20; GPR21; CMKLR1; P2RY13; INPP5K; ADGRE3; OR2B2; GPR88; NPFFR1; OR2AG1; OR10A5; OR10A2; OR10A4; OR2D2; S1PR5; CXCL16; OR51M1; OR51I1; OR51I2; OR52D1; NMUR1; PROK2; GPR35; CYSLTR2; TAS2R13; TAS2R10; XCL2; GPR160; GNG8; GPR132; RASD1; GPR55; PTGDR2; OR4D1; GPR34; CCL8; OR4E2; OR1L3; OR1A1; GNG11; OR7C1; OR1F1; OR1F2P; OR1L8; OR4E1; OR3A3; OR5C1; GPR152; CCL2; OR3A1; MRGPRD; GNG10; OR5K2; OR3A4P; OR1F12; OR1J1; OR1Q1; OR1L4; OR5B21; CCL7; CCL24; OR5K1; OR1L6; OR5B2;	GO:0007186~G protein-coupled receptor signaling pathway	207	1152	17.96875	0.00360266648048901	0.5485878504381	1	1	0.999999994869077	0.999999994869077	1
down	PLPP2; ALDH3B2; DEGS2; FA2H; CERS3; SPTSSB; ACER1;	GO:0030148~sphingolipid biosynthetic process	7	52	13.4615384615385	0.00381121905336801	0.0565408375839888	1	1	0.999999737396233	0.999999737396233	0.497977390233109
down	ANXA4; SCGB1A1; NQO1; UGT1A1; SERPINB3; UGT1A7; UGT1A8;	GO:0043086~negative regulation of catalytic activity	7	52	13.4615384615385	0.00381121905336801	0.0565408375839888	1	1	0.999999737396233	0.999999737396233	0.497977390233109
down	ZBTB7C; BMP2; KLF5; MEDAG; FRZB; CDS1; CCDC3;	GO:0045600~positive regulation of fat cell differentiation	7	52	13.4615384615385	0.00381121905336801	0.0565408375839888	1	1	0.999999737396233	0.999999737396233	0.497977390233109
down	NOL3; DKK1; CLDN7; CRYAB; ANXA1; HSPB1; TFAP2A; KRT18; CEACAM5; ANXA4; GLI2; MIF; NQO1; EPCAM; PRLR; AQP1; BTC; KDR; ID1; WNT5A; CX3CL1; DHCR24; FFAR4; VTCN1; TFAP2B; CARD14; ANGPTL4; BCL2L10; PLK2; TMEM14A;	GO:0043066~negative regulation of apoptotic process	30	489	6.13496932515337	0.00382610968111108	0.0565408375839888	1	1	0.999999737396233	0.999999737396233	0.497977390233109
down	CYP1A1; UGT1A7; UGT1A8;	GO:0009804~coumarin metabolic process	3	7	42.8571428571429	0.00394821413832758	0.0565408375839888	1	1	0.999999737396233	0.999999737396233	0.497977390233109
down	AQP1; AQP2; AQP3;	GO:0015793~glycerol transport	3	7	42.8571428571429	0.00394821413832758	0.0565408375839888	1	1	0.999999737396233	0.999999737396233	0.497977390233109
down	NFASC; CD9; UGT8;	GO:0030913~paranodal junction assembly	3	7	42.8571428571429	0.00394821413832758	0.0565408375839888	1	1	0.999999737396233	0.999999737396233	0.497977390233109
down	IDO1; ADCYAP1R1; LRP11;	GO:0033555~multicellular organismal response to stress	3	7	42.8571428571429	0.00394821413832758	0.0565408375839888	1	1	0.999999737396233	0.999999737396233	0.497977390233109
down	SERPINB3; CX3CL1; HILPDA;	GO:0035425~autocrine signaling	3	7	42.8571428571429	0.00394821413832758	0.0565408375839888	1	1	0.999999737396233	0.999999737396233	0.497977390233109
down	IL33; CX3CL1; IL34;	GO:0061518~microglial cell proliferation	3	7	42.8571428571429	0.00394821413832758	0.0565408375839888	1	1	0.999999737396233	0.999999737396233	0.497977390233109
down	AQP1; RHCG; RHBG;	GO:0072488~ammonium transmembrane transport	3	7	42.8571428571429	0.00394821413832758	0.0565408375839888	1	1	0.999999737396233	0.999999737396233	0.497977390233109
down	PLA2G10; MIF; PLA2R1;	GO:0090238~positive regulation of arachidonic acid secretion	3	7	42.8571428571429	0.00394821413832758	0.0565408375839888	1	1	0.999999737396233	0.999999737396233	0.497977390233109
down	ANXA8; SPINK6; SPINK5;	GO:1900004~negative regulation of serine-type endopeptidase activity	3	7	42.8571428571429	0.00394821413832758	0.0565408375839888	1	1	0.999999737396233	0.999999737396233	0.497977390233109
down	CCK; GJA1; NPAS2;	GO:2000987~positive regulation of behavioral fear response	3	7	42.8571428571429	0.00394821413832758	0.0565408375839888	1	1	0.999999737396233	0.999999737396233	0.497977390233109
down	RGS5; RGS11; ERBB3; PTK6; RGS7BP; RGS9BP;	GO:0009968~negative regulation of signal transduction	6	39	15.3846153846154	0.00403584848234939	0.057357967824905	1	1	0.999999737396233	0.999999737396233	0.5051741775861
down	MT1A; MT1G; STAR; MT1H; MT1X; MT1M;	GO:0071276~cellular response to cadmium ion	6	39	15.3846153846154	0.00403584848234939	0.057357967824905	1	1	0.999999737396233	0.999999737396233	0.5051741775861
down	MIF; EDN2; PLA2G4F; MGST1;	GO:0001516~prostaglandin biosynthetic process	4	16	25	0.00419001808599095	0.0578309613583263	1	1	0.999999737396233	0.999999737396233	0.509340017630835
down	CXCL10; BMP7; STC1; AQP3;	GO:0033280~response to vitamin D	4	16	25	0.00419001808599095	0.0578309613583263	1	1	0.999999737396233	0.999999737396233	0.509340017630835
down	EDN3; EDN2; KEL; BDKRB2;	GO:0042310~vasoconstriction	4	16	25	0.00419001808599095	0.0578309613583263	1	1	0.999999737396233	0.999999737396233	0.509340017630835
down	ALOX12; NOX5; DUOX2; DUOX1;	GO:0042554~superoxide anion generation	4	16	25	0.00419001808599095	0.0578309613583263	1	1	0.999999737396233	0.999999737396233	0.509340017630835
down	SPINT2; PARD3; PARD6G; CAP2; RHOD; RND3; RHOV;	GO:0007163~establishment or maintenance of cell polarity	7	53	13.2075471698113	0.00419011073587483	0.0578309613583263	1	1	0.999999737396233	0.999999737396233	0.509340017630835
down	ADCYAP1; NPY1R; BDKRB1; NMU; DLG2; NDN; ALOXE3;	GO:0019233~sensory perception of pain	7	53	13.2075471698113	0.00419011073587483	0.0578309613583263	1	1	0.999999737396233	0.999999737396233	0.509340017630835
down	CCL21; JUP; FUT1; EMP2; CX3CL1;	GO:0001954~positive regulation of cell-matrix adhesion	5	27	18.5185185185185	0.00425649100804093	0.0580740154987984	1	1	0.999999737396233	0.999999737396233	0.511480691022486
down	GLI2; TP63; HOXC10; HOXD9; HOXC9;	GO:0009954~proximal/distal pattern formation	5	27	18.5185185185185	0.00425649100804093	0.0580740154987984	1	1	0.999999737396233	0.999999737396233	0.511480691022486
down	RAMP2; ANXA1; HSPB1; MT1G; KDR;	GO:0035924~cellular response to vascular endothelial growth factor stimulus	5	27	18.5185185185185	0.00425649100804093	0.0580740154987984	1	1	0.999999737396233	0.999999737396233	0.511480691022486
up	IGHV4-39; IGLL5; IGHV3-30; IGHV1-2; IGHV3-43; TRDC; IGHV1-46; IGHV3-16; TRBC2; IGHV1-3; IGHV3-35; IGHV1-18; IGHV3-49; IGHV3-21; IGLC3; IGHE; IGHV3-23; IGHV3-13; IGHV3-7; IGHV2-5; IGHD; TRBC1; IGHV5-51; IGLC2; IGKC; IGHV6-1; IGHV4-34;	GO:0006910~phagocytosis, recognition	27	99	27.2727272727273	0.00437565644488958	0.646696283399121	1	1	0.999999994869077	0.999999994869077	1
down	TM7SF2; HMGCS2; DHCR24; NSDHL; ACAT2; NPC1L1;	GO:0006695~cholesterol biosynthetic process	6	40	15	0.00450977014578491	0.0610854064512093	1	1	0.999999737396233	0.999999737396233	0.538003195313753
down	DIRAS3; SFN; CDKN2B; CCND1; CCNB2; CCNO; CCNB1;	GO:0000079~regulation of cyclin-dependent protein serine/threonine kinase activity	7	55	12.7272727272727	0.00503254805479725	0.0667093142013478	1	1	0.999999737396233	0.999999737396233	0.587535162366161
down	DIO2; SLC5A5; DUOX2; DUOX1;	GO:0006590~thyroid hormone generation	4	17	23.5294117647059	0.00503792738467412	0.0667093142013478	1	1	0.999999737396233	0.999999737396233	0.587535162366161
down	AQP1; AQP2; AQP5; AQP3;	GO:0006833~water transport	4	17	23.5294117647059	0.00503792738467412	0.0667093142013478	1	1	0.999999737396233	0.999999737396233	0.587535162366161
down	KCNK1; KCNK7; KCNK15; KCNK5;	GO:0030322~stabilization of membrane potential	4	17	23.5294117647059	0.00503792738467412	0.0667093142013478	1	1	0.999999737396233	0.999999737396233	0.587535162366161
down	CTSV; AQP3; GRHL1; SERPINB13;	GO:0045616~regulation of keratinocyte differentiation	4	17	23.5294117647059	0.00503792738467412	0.0667093142013478	1	1	0.999999737396233	0.999999737396233	0.587535162366161
down	TH; CCND1; MAOB; STAR;	GO:0051412~response to corticosterone	4	17	23.5294117647059	0.00503792738467412	0.0667093142013478	1	1	0.999999737396233	0.999999737396233	0.587535162366161
up	IRGM; ACOD1; CD14; VIM; CSF3; TFPI; CCL2; XBP1; TNFRSF1B; TBXA2R; IL10; CD40; CASP1; CCR5; HAMP; IRF8; NR1H3; CEBPE; CARD16; LILRB2; TNIP2; LILRB1; NLRP7; LITAF; MYD88; PYCARD; DEFA4; PF4; PDCD1LG2; PF4V1; LY96; CD80; NR1H2; CD86; NR1I2; CXCL3; DEFA3; CD180; PPBP;	GO:0071222~cellular response to lipopolysaccharide	39	163	23.9263803680982	0.00514191689004595	0.717725899235581	1	1	0.999999994869077	0.999999994869077	1
down	SPINK5; OVOL1; OVOL2;	GO:0009913~epidermal cell differentiation	3	8	37.5	0.00529209939917163	0.0677677711457064	1	1	0.999999737396233	0.999999737396233	0.5968574088936
down	CEACAM1; PTN; EMP2;	GO:0010594~regulation of endothelial cell migration	3	8	37.5	0.00529209939917163	0.0677677711457064	1	1	0.999999737396233	0.999999737396233	0.5968574088936
down	MAOA; COMT; MAOB;	GO:0042420~dopamine catabolic process	3	8	37.5	0.00529209939917163	0.0677677711457064	1	1	0.999999737396233	0.999999737396233	0.5968574088936
down	SULT2B1; SFN; KDF1;	GO:0045606~positive regulation of epidermal cell differentiation	3	8	37.5	0.00529209939917163	0.0677677711457064	1	1	0.999999737396233	0.999999737396233	0.5968574088936
down	AGXT; ALDH4A1; HOGA1;	GO:0046487~glyoxylate metabolic process	3	8	37.5	0.00529209939917163	0.0677677711457064	1	1	0.999999737396233	0.999999737396233	0.5968574088936
down	HOXB1; FOXA1; DLX5;	GO:0048646~anatomical structure formation involved in morphogenesis	3	8	37.5	0.00529209939917163	0.0677677711457064	1	1	0.999999737396233	0.999999737396233	0.5968574088936
down	BMP2; BMP7; WWTR1;	GO:0048762~mesenchymal cell differentiation	3	8	37.5	0.00529209939917163	0.0677677711457064	1	1	0.999999737396233	0.999999737396233	0.5968574088936
down	COBL; PLS3; PLS1;	GO:0051639~actin filament network formation	3	8	37.5	0.00529209939917163	0.0677677711457064	1	1	0.999999737396233	0.999999737396233	0.5968574088936
down	WNT3; WNT4; WNT7B;	GO:0061180~mammary gland epithelium development	3	8	37.5	0.00529209939917163	0.0677677711457064	1	1	0.999999737396233	0.999999737396233	0.5968574088936
down	BMP7; ITGA8; IRX3; SOX17; ROBO2;	GO:0001656~metanephros development	5	29	17.2413793103448	0.00556119318313819	0.07071387335359	1	1	0.999999737396233	0.999999737396233	0.622804889538233
down	CYP1A1; PRLR; DHRS11; TFCP2L1; STAR;	GO:0006694~steroid biosynthetic process	5	29	17.2413793103448	0.00556119318313819	0.07071387335359	1	1	0.999999737396233	0.999999737396233	0.622804889538233
down	CA12; AQP1; CA9; CYB5R2; SLC26A9; SLC4A11;	GO:0015701~bicarbonate transport	6	42	14.2857142857143	0.00557870642661584	0.07071387335359	1	1	0.999999737396233	0.999999737396233	0.622804889538233
up	LAMTOR5; TNF; APOA2; CD74; ELANE; TLR8; TLR7; TLR9;	GO:0045416~positive regulation of interleukin-8 biosynthetic process	8	15	53.3333333333333	0.00572239705111133	0.759940295345008	1	1	0.999999994869077	0.999999994869077	1
up	CCL24; CREB3; RNASE2; CCL2; TYMP; FPR3; CCR6; NCKAP1L; CCL8; CCL7; PLAUR; C3AR1; CMTM8; CMTM2; CMTM5; CMTM7; CMTM3; CMKLR1; CXCL16; PROK2; PTGDR2; CCR3; CXCR3; CCR10; CCR8; FES; CXCR5; CXCR1; CCR7; CCR2; CCR5;	GO:0006935~chemotaxis	31	122	25.4098360655738	0.00574681218370354	0.759940295345008	1	1	0.999999994869077	0.999999994869077	1
down	F12; C1QA; C1QB; C1QC; SLPI; ANXA1; S100B; KRT16; MIF; S100A7; CRISP3; DEFB1; LCN2; MST1R; TRIM29; COLEC12; SUSD4; IL34; TRIL; CLEC10A; PGLYRP4; PGLYRP3; LGR4; TRIM31; RNASE7; IL1RL2; IL36B; IL36G; IL36RN; IL36A;	GO:0045087~innate immune response	30	505	5.94059405940594	0.00583498944127392	0.0737134019651843	1	1	0.999999737396233	0.999999737396233	0.649222917529284
down	CTSV; CRYAB; TH; TP63;	GO:0010259~multicellular organism aging	4	18	22.2222222222222	0.0059935351672441	0.0740057932938007	1	1	0.999999737396233	0.999999737396233	0.65179812293785
down	TMPRSS2; F12; CTSE; KLK6;	GO:0016540~protein autoprocessing	4	18	22.2222222222222	0.0059935351672441	0.0740057932938007	1	1	0.999999737396233	0.999999737396233	0.65179812293785
down	PRDX1; IL18; RAET1G; RAET1E;	GO:0042267~natural killer cell mediated cytotoxicity	4	18	22.2222222222222	0.0059935351672441	0.0740057932938007	1	1	0.999999737396233	0.999999737396233	0.65179812293785
down	SLCO2B1; SLCO2A1; SLCO4A1; SLCO6A1;	GO:0043252~sodium-independent organic anion transport	4	18	22.2222222222222	0.0059935351672441	0.0740057932938007	1	1	0.999999737396233	0.999999737396233	0.65179812293785
down	DSP; KRT20; KRT17; TCHH;	GO:0045109~intermediate filament organization	4	18	22.2222222222222	0.0059935351672441	0.0740057932938007	1	1	0.999999737396233	0.999999737396233	0.65179812293785
down	CXCL10; S100A7; CXCL17; S100A14;	GO:0090026~positive regulation of monocyte chemotaxis	4	18	22.2222222222222	0.0059935351672441	0.0740057932938007	1	1	0.999999737396233	0.999999737396233	0.65179812293785
down	SDC1; CCND1; SLC6A1; TNNT2; AQP3; S100A16; TRPV6;	GO:0051592~response to calcium ion	7	57	12.280701754386	0.00599620500035059	0.0740057932938007	1	1	0.999999737396233	0.999999737396233	0.65179812293785
down	DLX3; CEACAM1; GJA4; FOXF1; STRA6; APLNR;	GO:0001568~blood vessel development	6	43	13.953488372093	0.00617749894859931	0.0754655108017505	1	1	0.999999737396233	0.999999737396233	0.664654429037077
down	RGS5; RAMP2; RGS11; ADCYAP1; GNG4; KCTD8;	GO:0008277~regulation of G protein-coupled receptor signaling pathway	6	43	13.953488372093	0.00617749894859931	0.0754655108017505	1	1	0.999999737396233	0.999999737396233	0.664654429037077
down	CEACAM1; FUT3; PHLDA2; ROBO4; SRCIN1; CAMSAP3; RHOD; RND3; AMOTL2;	GO:0030334~regulation of cell migration	9	89	10.1123595505618	0.00629158580787792	0.0754655108017505	1	1	0.999999737396233	0.999999737396233	0.664654429037077
down	FOXP2; RBFOX2; HR; CRYAB; TFAP2A; BMP2; BMP7; HOXA7; SOX18; ID1; WNT5A; HNF4A; ID4; PAX9; WNT4; PITX1; ELF3; FOXF2; NR0B2; ERN2; NOSTRIN; CIART; TFAP2B; ATOH8; SOX7; LGR4; TRIM6; TP63; HEY2; OVOL1; OVOL2;	GO:0045892~negative regulation of transcription, DNA-templated	31	530	5.84905660377358	0.0063044648616104	0.0754655108017505	1	1	0.999999737396233	0.999999737396233	0.664654429037077
down	MT1X; MT1A; MT1H; MT1G; MT1M;	GO:0006882~cellular zinc ion homeostasis	5	30	16.6666666666667	0.00630917714110735	0.0754655108017505	1	1	0.999999737396233	0.999999737396233	0.664654429037077
down	SULT2B1; CYP11A1; CYP2C9; STAR; VLDLR; NR0B2; NSDHL; CH25H;	GO:0008203~cholesterol metabolic process	8	73	10.958904109589	0.00634181049906368	0.0754655108017505	1	1	0.999999737396233	0.999999737396233	0.664654429037077
down	BMP7; HOXD3; WNT5A; LUM; PITX1; HES5; IL17F;	GO:0051216~cartilage development	7	58	12.0689655172414	0.00652664479894605	0.0754655108017505	1	1	0.999999737396233	0.999999737396233	0.664654429037077
up	HLA-E; HLA-G; HLA-F; HLA-A; HLA-B; HLA-H; FCGRT;	GO:0002476~antigen processing and presentation of endogenous peptide antigen via MHC class Ib	7	12	58.3333333333333	0.00674507343540598	0.788232418905001	1	1	0.999999994869077	0.999999994869077	1
up	HLA-B; HLA-A; HLA-G; HLA-H; FCGRT; HLA-F; HLA-E;	GO:0002486~antigen processing and presentation of endogenous peptide antigen via MHC class I via ER pathway, TAP-independent	7	12	58.3333333333333	0.00674507343540598	0.788232418905001	1	1	0.999999994869077	0.999999994869077	1
up	IL2RA; LYN; CTLA4; HLA-G; PDCD1; FCRLB; FOXP3;	GO:0050777~negative regulation of immune response	7	12	58.3333333333333	0.00674507343540598	0.788232418905001	1	1	0.999999994869077	0.999999994869077	1
down	ANXA1; CX3CL1; CCL17; CCL21; CCL19; CCL11;	GO:0002548~monocyte chemotaxis	6	44	13.6363636363636	0.00682168420175855	0.0754655108017505	1	1	0.999999737396233	0.999999737396233	0.664654429037077
down	NME1; SDC1; AGXT; ALDH3A1; DUOX2; DUOX1;	GO:0051591~response to cAMP	6	44	13.6363636363636	0.00682168420175855	0.0754655108017505	1	1	0.999999737396233	0.999999737396233	0.664654429037077
down	SFN; KDF1; EXPH5;	GO:0003334~keratinocyte development	3	9	33.3333333333333	0.00687878589930668	0.0754655108017505	1	1	0.999999737396233	0.999999737396233	0.664654429037077
down	AKR7A3; ALDH3A1; ALDH7A1;	GO:0006081~cellular aldehyde metabolic process	3	9	33.3333333333333	0.00687878589930668	0.0754655108017505	1	1	0.999999737396233	0.999999737396233	0.664654429037077
down	IDO1; TDO2; AADAT;	GO:0006569~tryptophan catabolic process	3	9	33.3333333333333	0.00687878589930668	0.0754655108017505	1	1	0.999999737396233	0.999999737396233	0.664654429037077
down	CES2; AADAC; AADACL2;	GO:0009056~catabolic process	3	9	33.3333333333333	0.00687878589930668	0.0754655108017505	1	1	0.999999737396233	0.999999737396233	0.664654429037077
down	FUT1; FUT6; FUT2;	GO:0042355~L-fucose catabolic process	3	9	33.3333333333333	0.00687878589930668	0.0754655108017505	1	1	0.999999737396233	0.999999737396233	0.664654429037077
down	SOX18; ID1; EMP2;	GO:0043534~blood vessel endothelial cell migration	3	9	33.3333333333333	0.00687878589930668	0.0754655108017505	1	1	0.999999737396233	0.999999737396233	0.664654429037077
down	AKR1B10; AKR1C2; AKR1C1;	GO:0044597~daunorubicin metabolic process	3	9	33.3333333333333	0.00687878589930668	0.0754655108017505	1	1	0.999999737396233	0.999999737396233	0.664654429037077
down	AKR1B10; AKR1C2; AKR1C1;	GO:0044598~doxorubicin metabolic process	3	9	33.3333333333333	0.00687878589930668	0.0754655108017505	1	1	0.999999737396233	0.999999737396233	0.664654429037077
down	ELN; NPPC; PDE1A;	GO:0048660~regulation of smooth muscle cell proliferation	3	9	33.3333333333333	0.00687878589930668	0.0754655108017505	1	1	0.999999737396233	0.999999737396233	0.664654429037077
down	WNT9A; WNT9B; WNT2B;	GO:0061303~cornea development in camera-type eye	3	9	33.3333333333333	0.00687878589930668	0.0754655108017505	1	1	0.999999737396233	0.999999737396233	0.664654429037077
down	AGTR1; APLNR; FGFBP1;	GO:1903589~positive regulation of blood vessel endothelial cell proliferation involved in sprouting angiogenesis	3	9	33.3333333333333	0.00687878589930668	0.0754655108017505	1	1	0.999999737396233	0.999999737396233	0.664654429037077
down	UNC13B; NTF4; GABRB2; SLITRK6;	GO:0060384~innervation	4	19	21.0526315789474	0.00706242268304846	0.0770296799616216	1	1	0.999999737396233	0.999999737396233	0.678430681908441
down	DKK1; PAX9; DLX5; STRA6; CRISPLD1;	GO:0060325~face morphogenesis	5	31	16.1290322580645	0.00712498123822725	0.0774867524806627	1	1	0.999999737396233	0.999999737396233	0.682456299318887
down	RHOD; SHROOM2; AIF1L; RND3; PLS3; PLS1;	GO:0051017~actin filament bundle assembly	6	45	13.3333333333333	0.00751313141848153	0.0813372621627933	1	1	0.999999737396233	0.999999737396233	0.716369252230602
down	RGS5; RGS11; ARHGEF15; RASAL1; HRAS; ADCYAP1; CCL11; WNT4; ARHGAP8; PLEKHG6; ARHGAP40; PREX2; ASAP3; GRHL3; AGAP11; CCL19; RASAL2; FZD10; CCL21; CX3CL1; CCL17;	GO:0043547~positive regulation of GTPase activity	21	322	6.52173913043478	0.00754519523661479	0.0813493463441916	1	1	0.999999737396233	0.999999737396233	0.716475682368056
down	OVOL1; CTSV; GJB3; CCNB1; GJA1; TSPAN8; ADCYAP1R1; HSPA2; BNC1; TYRO3; WFDC2; ODF4; MORN2; SHISA6; SPATA19; HORMAD1; FOXJ1; LGR4; TP63; SOX17; ELL3; BCL2L10; NPAP1; THEG; GGT5;	GO:0007283~spermatogenesis	25	407	6.14250614250614	0.00765032915979824	0.0822465186463123	1	1	0.999999737396233	0.999999737396233	0.724377431629125
down	UNC13B; GJB6; TH; NME1; CMA1; STAR; ENDOG;	GO:0071333~cellular response to glucose stimulus	7	60	11.6666666666667	0.00769108034084343	0.0824483812538415	1	1	0.999999737396233	0.999999737396233	0.726155314992344
down	EFNA1; EPHA2; ID1; EMP2; GPNMB;	GO:0045765~regulation of angiogenesis	5	32	15.625	0.00801157650584794	0.0853961223009701	1	1	0.999999737396233	0.999999737396233	0.75211722953865
down	EPHB3; CNTN4; NDN; CRTAC1;	GO:0007413~axonal fasciculation	4	20	20	0.00824986589265098	0.086988372853794	1	1	0.999999737396233	0.999999737396233	0.766140806280234
down	CYP1A1; CYP2C9; COMT; UGT1A1;	GO:0008210~estrogen metabolic process	4	20	20	0.00824986589265098	0.086988372853794	1	1	0.999999737396233	0.999999737396233	0.766140806280234
down	ADRA2A; GHR; IGFBP2; ROBO2; RAMP2; RAMP3;	GO:0032870~cellular response to hormone stimulus	6	46	13.0434782608696	0.00825369422599964	0.086988372853794	1	1	0.999999737396233	0.999999737396233	0.766140806280234
down	DEFB4A; CXCL10; MIF; NTF3; CX3CL1; GPNMB;	GO:0050918~positive chemotaxis	6	46	13.0434782608696	0.00825369422599964	0.086988372853794	1	1	0.999999737396233	0.999999737396233	0.766140806280234
down	GSTA1; MGST1; GPX2; GPX3; TXNDC17; GSTO2; DUOX2; DUOX1;	GO:0098869~cellular oxidant detoxification	8	77	10.3896103896104	0.00843069441000666	0.0886049451718347	1	1	0.999999737396233	0.999999737396233	0.780378594372162
down	CCL21; DEFB4A; CXCL14; C1QC; SLPI; HLA-DQB2; CD1A; CTSG; CD1E; IL1RN; ENDOU; TNFSF9; DEFB1; CX3CL1; MS4A2; GBP6; CCL19; IL36B; IL36A; CXCL10; RAET1G; IGLV3-9; RAET1L; CXCL9; RAET1E; CXCL11;	GO:0006955~immune response	26	433	6.00461893764434	0.00861943958799549	0.0888864988420123	1	1	0.999999737396233	0.999999737396233	0.782858348261152
up	PSMB11; TAPBP; HLA-B; HLA-H; HLA-A; CYBA; HLA-E; HLA-G; PSMA2; PSMB8; PSMB9; HLA-F; PSMB10; PSMB3; B2M; TAP1; PSME1; PSMA8; PSMF1; FCGR1B; PSME2;	GO:0002479~antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-dependent	21	75	28	0.00870483726066928	0.950908852931808	1	1	0.999999994869077	0.999999994869077	1
down	CPE; FOXF1; HEY2;	GO:0003214~cardiac left ventricle morphogenesis	3	10	30	0.00871807877768138	0.0888864988420123	1	1	0.999999737396233	0.999999737396233	0.782858348261152
down	CPS1; WNT5A; FOXF1;	GO:0007494~midgut development	3	10	30	0.00871807877768138	0.0888864988420123	1	1	0.999999737396233	0.999999737396233	0.782858348261152
down	GCAT; ALDH1L1; AADAT;	GO:0009058~biosynthetic process	3	10	30	0.00871807877768138	0.0888864988420123	1	1	0.999999737396233	0.999999737396233	0.782858348261152
down	EMP1; EMP2; LPAR3;	GO:0032060~bleb assembly	3	10	30	0.00871807877768138	0.0888864988420123	1	1	0.999999737396233	0.999999737396233	0.782858348261152
down	PLA2G10; MIF; SLC7A2;	GO:0043030~regulation of macrophage activation	3	10	30	0.00871807877768138	0.0888864988420123	1	1	0.999999737396233	0.999999737396233	0.782858348261152
down	DDR1; SHROOM2; STRA6;	GO:0043583~ear development	3	10	30	0.00871807877768138	0.0888864988420123	1	1	0.999999737396233	0.999999737396233	0.782858348261152
down	CCK; ALOX12; KDR;	GO:0051901~positive regulation of mitochondrial depolarization	3	10	30	0.00871807877768138	0.0888864988420123	1	1	0.999999737396233	0.999999737396233	0.782858348261152
down	PDLIM4; PDLIM3; PRICKLE4;	GO:0061061~muscle structure development	3	10	30	0.00871807877768138	0.0888864988420123	1	1	0.999999737396233	0.999999737396233	0.782858348261152
down	CYP1A1; CYP2C9; CYP2C19;	GO:0097267~omega-hydroxylase P450 pathway	3	10	30	0.00871807877768138	0.0888864988420123	1	1	0.999999737396233	0.999999737396233	0.782858348261152
down	PSCA; SLURP1; LYPD6;	GO:0099601~regulation of neurotransmitter receptor activity	3	10	30	0.00871807877768138	0.0888864988420123	1	1	0.999999737396233	0.999999737396233	0.782858348261152
down	SLC44A4; SLC44A3; SLC44A5; LPIN3; STARD10;	GO:0006656~phosphatidylcholine biosynthetic process	5	33	15.1515151515152	0.00897186108310333	0.0900201984734563	1	1	0.999999737396233	0.999999737396233	0.792843286721536
down	ERBB3; TYRO3; NYAP1; PREX2; PIK3C2G;	GO:0014065~phosphatidylinositol 3-kinase signaling	5	33	15.1515151515152	0.00897186108310333	0.0900201984734563	1	1	0.999999737396233	0.999999737396233	0.792843286721536
down	CX3CL1; CCL21; CCL19; CCL17; CCL11;	GO:0048247~lymphocyte chemotaxis	5	33	15.1515151515152	0.00897186108310333	0.0900201984734563	1	1	0.999999737396233	0.999999737396233	0.792843286721536
down	WNT3; CX3CL1; HES5; HEY2; HES2;	GO:0050767~regulation of neurogenesis	5	33	15.1515151515152	0.00897186108310333	0.0900201984734563	1	1	0.999999737396233	0.999999737396233	0.792843286721536
down	SPINT2; BMP2; BMP7; DLX5; TMEM100;	GO:0071773~cellular response to BMP stimulus	5	33	15.1515151515152	0.00897186108310333	0.0900201984734563	1	1	0.999999737396233	0.999999737396233	0.792843286721536
down	CEACAM5; CEACAM6; LGALS7; CXADR; NECTIN4; IGSF21;	GO:0007157~heterophilic cell-cell adhesion via plasma membrane cell adhesion molecules	6	47	12.7659574468085	0.00904520650972629	0.0900201984734563	1	1	0.999999737396233	0.999999737396233	0.792843286721536
down	TAX1BP3; DKK1; SOSTDC1; TSKU; FRZB; DKK4;	GO:0030178~negative regulation of Wnt signaling pathway	6	47	12.7659574468085	0.00904520650972629	0.0900201984734563	1	1	0.999999737396233	0.999999737396233	0.792843286721536
down	TFF1; TH; GJA1; BMP7; GNAI1; ANXA1;	GO:0043434~response to peptide hormone	6	47	12.7659574468085	0.00904520650972629	0.0900201984734563	1	1	0.999999737396233	0.999999737396233	0.792843286721536
down	CIDEA; ID1; ACOT11; LGR4; HOXC10; NOVA2;	GO:0120163~negative regulation of cold-induced thermogenesis	6	47	12.7659574468085	0.00904520650972629	0.0900201984734563	1	1	0.999999737396233	0.999999737396233	0.792843286721536
down	CXADR; TJP1; OCLN; MARVELD2;	GO:0045216~cell-cell junction organization	4	21	19.047619047619	0.00956082020036431	0.0946495973397543	1	1	0.999999737396233	0.999999737396233	0.833616222961872
down	KLK8; WNT5A; CDH8; IGSF9;	GO:0050807~regulation of synapse organization	4	21	19.047619047619	0.00956082020036431	0.0946495973397543	1	1	0.999999737396233	0.999999737396233	0.833616222961872
down	RBFOX2; FGF1; FGFR3; FGFBP1; ESRP1; ESRP2; FGF22; FLRT3;	GO:0008543~fibroblast growth factor receptor signaling pathway	8	79	10.126582278481	0.00965012091098383	0.0952822464684508	1	1	0.999999737396233	0.999999737396233	0.839188212615785
down	FOXH1; FOLR1; SOX18; WNT5A; OVOL2; SOX17; NDRG4;	GO:0001947~heart looping	7	63	11.1111111111111	0.00971558299258468	0.0956768172918051	1	1	0.999999737396233	0.999999737396233	0.84266335301469
down	SNCG; CSTB; HOXD9; NTF4; PREX2; SLITRK6;	GO:0008344~adult locomotory behavior	6	48	12.5	0.00988947838920773	0.0968807386848757	1	1	0.999999737396233	0.999999737396233	0.85326676214312
down	EFNA1; ITGA8; EPHB3; TYRO3; SRCIN1; LAMB4;	GO:0034446~substrate adhesion-dependent cell spreading	6	48	12.5	0.00988947838920773	0.0968807386848757	1	1	0.999999737396233	0.999999737396233	0.85326676214312
down	AQP1; AQP2; TFAP2B; AQP3; CYP4F12;	GO:0003091~renal water homeostasis	5	34	14.7058823529412	0.0100086519209064	0.0973350494121392	1	1	0.999999737396233	0.999999737396233	0.857268055367359
down	FOXP2; EDN2; FOXF1; ABCA12; STRA6;	GO:0048286~lung alveolus development	5	34	14.7058823529412	0.0100086519209064	0.0973350494121392	1	1	0.999999737396233	0.999999737396233	0.857268055367359
down	KCNK1; CACNA1G; SLC34A2; SCNN1A; SCNN1B; SCNN1G; SHROOM2; SLC4A11;	GO:0035725~sodium ion transmembrane transport	8	80	10	0.0103067909797647	0.0973350494121392	1	1	0.999999737396233	0.999999737396233	0.857268055367359
down	DEFB4A; CTSG; S100A7; NOS2; DEFB1; LCE3A; IL22RA1; RNASE7;	GO:0050829~defense response to Gram-negative bacterium	8	80	10	0.0103067909797647	0.0973350494121392	1	1	0.999999737396233	0.999999737396233	0.857268055367359
down	PRLR; GJA1; ADCYAP1; ACADL; ESRRG; LCN2; IL18; FFAR4; DIO2;	GO:0120162~positive regulation of cold-induced thermogenesis	9	97	9.27835051546392	0.0103387759042802	0.0973350494121392	1	1	0.999999737396233	0.999999737396233	0.857268055367359
down	C2CD4B; PRLR; FUT1; FUT2; IL18; SPINK5;	GO:0030155~regulation of cell adhesion	6	49	12.2448979591837	0.0107882923165917	0.0973350494121392	1	1	0.999999737396233	0.999999737396233	0.857268055367359
down	WNT5A; FOXA1; TJP1;	GO:2000049~positive regulation of cell-cell adhesion mediated by cadherin	3	11	27.2727272727273	0.0108178879543875	0.0973350494121392	1	1	0.999999737396233	0.999999737396233	0.857268055367359
up	HLA-E; HLA-G; HLA-F; CLEC12B; LILRB1; KIR2DL4;	GO:0045953~negative regulation of natural killer cell mediated cytotoxicity	6	10	60	0.0109099215380832	0.959691534896076	1	1	0.999999994869077	0.999999994869077	1
down	CIDEA; EDN2; ACADL; NMU;	GO:0001659~temperature homeostasis	4	22	18.1818181818182	0.0109999083563717	0.0980324374183051	1	1	0.999999737396233	0.999999737396233	0.863410225772502
down	TFF1; CYP1A1; TH; LRP11;	GO:0035902~response to immobilization stress	4	22	18.1818181818182	0.0109999083563717	0.0980324374183051	1	1	0.999999737396233	0.999999737396233	0.863410225772502
down	CCND1; CCNB1; CCNO; CCNB2;	GO:0044772~mitotic cell cycle phase transition	4	22	18.1818181818182	0.0109999083563717	0.0980324374183051	1	1	0.999999737396233	0.999999737396233	0.863410225772502
down	GLI2; BMP7; HNF1B; RASIP1;	GO:0048754~branching morphogenesis of an epithelial tube	4	22	18.1818181818182	0.0109999083563717	0.0980324374183051	1	1	0.999999737396233	0.999999737396233	0.863410225772502
down	KLK8; BRINP1; CIDEA; EMP1; EMP2;	GO:0008219~cell death	5	35	14.2857142857143	0.01112467708429	0.0989094512328342	1	1	0.999999737396233	0.999999737396233	0.871134431306402
down	HNF1B; NR0B2; CIART; NPAS2; LGR4; ID4; ID1;	GO:0032922~circadian regulation of gene expression	7	65	10.7692307692308	0.0112651009283036	0.0999211789196099	1	1	0.999999737396233	0.999999737396233	0.880045114886898
down	CHP2; RASAL1; WNT5A; HPCA; ENDOG; ACER1; SYT7; SYT8;	GO:0071277~cellular response to calcium ion	8	82	9.75609756097561	0.0117186079467877	0.103698625038555	1	1	0.999999737396233	0.999999737396233	0.913314568266755
up	HLA-DRA; HLA-DRB1; HLA-DMA; HLA-DMB;	GO:0002503~peptide antigen assembly with MHC class II protein complex	4	4	100	0.0120170477787291	0.959691534896076	1	1	0.999999994869077	0.999999994869077	1
down	CXCL10; EDN3; ELN; BDKRB2; MEOX2;	GO:0008015~blood circulation	5	36	13.8888888888889	0.0123225686513145	0.108276996673846	1	1	0.999999737396233	0.999999737396233	0.9536380876181
down	CXCL10; HSPA2; CDH8; LRP11; ACOT11;	GO:0009409~response to cold	5	36	13.8888888888889	0.0123225686513145	0.108276996673846	1	1	0.999999737396233	0.999999737396233	0.9536380876181
down	TFAP2A; HES5; TFAP2B; KLK6; BCL6B;	GO:0045595~regulation of cell differentiation	5	36	13.8888888888889	0.0123225686513145	0.108276996673846	1	1	0.999999737396233	0.999999737396233	0.9536380876181
down	ANXA1; ADCYAP1; UGT1A1; STC1;	GO:0071385~cellular response to glucocorticoid stimulus	4	23	17.3913043478261	0.0125714112436477	0.110205455575155	1	1	0.999999737396233	0.999999737396233	0.970622783492458
up	LAMTOR5; TNF; IFNB1; IFNG; FGR; IFITM1; CCL4; IFNGR1; CFL1; GATA3; PSMA2; IFNGR2; XCL1; IFNAR2; NPC2; CCL8; IFITM2; BST2; LILRB1; IRF7; ISG20; FOXP3; BATF3; TLR8; PIM2; TBX21;	GO:0009615~response to virus	26	104	25	0.0126391777485607	0.959691534896076	1	1	0.999999994869077	0.999999994869077	1
down	DKK1; SOX7; SOX17;	GO:0001706~endoderm formation	3	12	25	0.0131843778164937	0.113981072736139	1	1	0.999999737396233	0.999999737396233	1
down	EDN3; EDN2; PTN;	GO:0002690~positive regulation of leukocyte chemotaxis	3	12	25	0.0131843778164937	0.113981072736139	1	1	0.999999737396233	0.999999737396233	1
down	ADH1B; ADH1C; ADH7;	GO:0006069~ethanol oxidation	3	12	25	0.0131843778164937	0.113981072736139	1	1	0.999999737396233	0.999999737396233	1
down	BMP2; PTN; WNT5A;	GO:0045778~positive regulation of ossification	3	12	25	0.0131843778164937	0.113981072736139	1	1	0.999999737396233	0.999999737396233	1
down	EDN3; EDN2; GPR62;	GO:0048016~inositol phosphate-mediated signaling	3	12	25	0.0131843778164937	0.113981072736139	1	1	0.999999737396233	0.999999737396233	1
down	CEACAM1; ALOX12; CD9;	GO:0090331~negative regulation of platelet aggregation	3	12	25	0.0131843778164937	0.113981072736139	1	1	0.999999737396233	0.999999737396233	1
down	EPCAM; BMP7; SDC1; NPNT; ROBO2;	GO:0001657~ureteric bud development	5	37	13.5135135135135	0.0136048562043265	0.117076652473929	1	1	0.999999737396233	0.999999737396233	1
down	NR2F6; BMP7; HNF4A; ESRRG; HNF4G; NR0B2;	GO:0043401~steroid hormone mediated signaling pathway	6	52	11.5384615384615	0.013829317742823	0.118735927164925	1	1	0.999999737396233	0.999999737396233	1
up	SOCS1; F13A1; TIMP1; TNF; IL2RA; CD4; IGHE; PF4; ITGB2; IL5; FCER2; CSF1R; VIM; CSF3; CCL4; CCL2; OSM; ALOX15; VCAM1; TNFRSF1A; TNFRSF1B; IL10; GATA3; IL32; PTPN6; CASP1; AKT1; IL2RG; CD80; OPRM1; FLT3; OPRD1; CCR2; CD86; STAT5A; FASLG; CEBPD; CCR5; IL2; GRB2; IL5RA; IL10RA; IL16; IRF4; BATF; IL31; IL31RA; IL22; IL26; IL20; F3; IFNA21; IFNGR1; IFNA5; IFNB1; IFNGR2; IFNAR2;	GO:0019221~cytokine-mediated signaling pathway	57	278	20.5035971223022	0.0139048615852244	0.959691534896076	1	1	0.999999994869077	0.999999994869077	1
down	SYT7; ADRA2A; ADRA2C; NOS2; HNF4A; TFAP2B; KCNS3;	GO:0050796~regulation of insulin secretion	7	68	10.2941176470588	0.0139137046304489	0.119187716377727	1	1	0.999999737396233	0.999999737396233	1
down	EFNA1; FOXA1; VASN; OVOL2;	GO:0010719~negative regulation of epithelial to mesenchymal transition	4	24	16.6666666666667	0.0142792612851899	0.120420750864188	1	1	0.999999737396233	0.999999737396233	1
down	CX3CL1; CXCL10; CXCL11; CXCL9;	GO:0030595~leukocyte chemotaxis	4	24	16.6666666666667	0.0142792612851899	0.120420750864188	1	1	0.999999737396233	0.999999737396233	1
down	GCNT3; GALNT18; A4GNT; B3GALT5; B3GNT6; B3GALNT1;	GO:0006493~protein O-linked glycosylation	6	53	11.3207547169811	0.014963442122775	0.120420750864188	1	1	0.999999737396233	0.999999737396233	1
down	IL33; ADCYAP1; WNT5A; RAB7B; IL1RL2; IL36A;	GO:0032755~positive regulation of interleukin-6 production	6	53	11.3207547169811	0.014963442122775	0.120420750864188	1	1	0.999999737396233	0.999999737396233	1
down	NFASC; MAL; KEL; KLK6; MAL2; MALL;	GO:0042552~myelination	6	53	11.3207547169811	0.014963442122775	0.120420750864188	1	1	0.999999737396233	0.999999737396233	1
down	SDC1; GPC1; HS6ST2; HS3ST6; HS3ST3A1;	GO:0006024~glycosaminoglycan biosynthetic process	5	38	13.1578947368421	0.0149739609103118	0.120420750864188	1	1	0.999999737396233	0.999999737396233	1
down	SRRM4; ESRP1; ESRP2; AHNAK2; RBM20;	GO:0043484~regulation of RNA splicing	5	38	13.1578947368421	0.0149739609103118	0.120420750864188	1	1	0.999999737396233	0.999999737396233	1
down	CACNA1G; JUP; DSP; GJA5; KCNJ5;	GO:0086091~regulation of heart rate by cardiac conduction	5	38	13.1578947368421	0.0149739609103118	0.120420750864188	1	1	0.999999737396233	0.999999737396233	1
up	SOCS1; HLA-G; IL2; LILRB2; BTN2A2; DUSP10;	GO:0045591~positive regulation of regulatory T cell differentiation	6	11	54.5454545454545	0.0150728697323571	0.959691534896076	1	1	0.999999994869077	0.999999994869077	1
down	AKR1B15; STAR; DHRS11;	GO:0006703~estrogen biosynthetic process	3	13	23.0769230769231	0.0158221078284631	0.120420750864188	1	1	0.999999737396233	0.999999737396233	1
down	NQO1; NOS2; SLC7A2;	GO:0006809~nitric oxide biosynthetic process	3	13	23.0769230769231	0.0158221078284631	0.120420750864188	1	1	0.999999737396233	0.999999737396233	1
down	CDH3; TGM1; TP63;	GO:0010838~positive regulation of keratinocyte proliferation	3	13	23.0769230769231	0.0158221078284631	0.120420750864188	1	1	0.999999737396233	0.999999737396233	1
down	NQO1; SOD3; PRDX1;	GO:0019430~removal of superoxide radicals	3	13	23.0769230769231	0.0158221078284631	0.120420750864188	1	1	0.999999737396233	0.999999737396233	1
down	ID1; CX3CL1; SYNPO2L;	GO:0032233~positive regulation of actin filament bundle assembly	3	13	23.0769230769231	0.0158221078284631	0.120420750864188	1	1	0.999999737396233	0.999999737396233	1
down	MAL; SHROOM2; SHROOM3;	GO:0045176~apical protein localization	3	13	23.0769230769231	0.0158221078284631	0.120420750864188	1	1	0.999999737396233	0.999999737396233	1
down	WNT4; FOXF1; HEY2;	GO:0051145~smooth muscle cell differentiation	3	13	23.0769230769231	0.0158221078284631	0.120420750864188	1	1	0.999999737396233	0.999999737396233	1
down	MMP12; WNT5A; TRIM6;	GO:0060340~positive regulation of type I interferon-mediated signaling pathway	3	13	23.0769230769231	0.0158221078284631	0.120420750864188	1	1	0.999999737396233	0.999999737396233	1
down	EPHA2; CCL11; DDR1;	GO:0060444~branching involved in mammary gland duct morphogenesis	3	13	23.0769230769231	0.0158221078284631	0.120420750864188	1	1	0.999999737396233	0.999999737396233	1
down	TFAP2A; GRHL3; STRA6;	GO:0061029~eyelid development in camera-type eye	3	13	23.0769230769231	0.0158221078284631	0.120420750864188	1	1	0.999999737396233	0.999999737396233	1
down	CEACAM1; EPCAM; FLRT3;	GO:0098742~cell-cell adhesion via plasma-membrane adhesion molecules	3	13	23.0769230769231	0.0158221078284631	0.120420750864188	1	1	0.999999737396233	0.999999737396233	1
down	OAT; FOLH1; ASPG; GPT2;	GO:0008652~cellular amino acid biosynthetic process	4	25	16	0.0161270382237524	0.122239691748523	1	1	0.999999737396233	0.999999737396233	1
down	SASH1; FGF1; FUT1; KDR; WNT5A; ATOH8;	GO:0010595~positive regulation of endothelial cell migration	6	54	11.1111111111111	0.0161604789436334	0.122246203622001	1	1	0.999999737396233	0.999999737396233	1
up	TESPA1; RAB29; KCNN4; ADA; LCK; CCR7; TRAT1;	GO:0050862~positive regulation of T cell receptor signaling pathway	7	15	46.6666666666667	0.0161969507572775	0.959691534896076	1	1	0.999999994869077	0.999999994869077	1
up	IL2RA; CD74; XBP1; MDK; GATA3; CD27; RHOH; PIK3R6;	GO:0045582~positive regulation of T cell differentiation	8	19	42.1052631578947	0.0162818715796328	0.959691534896076	1	1	0.999999994869077	0.999999994869077	1
down	DKK1; BMP7; GJA5; DLX5; HOXC10;	GO:0030326~embryonic limb morphogenesis	5	39	12.8205128205128	0.0164321901794802	0.123802364565079	1	1	0.999999737396233	0.999999737396233	1
down	TFAP2A; BMP2; BMP7; PTN; WNT4;	GO:0030501~positive regulation of bone mineralization	5	39	12.8205128205128	0.0164321901794802	0.123802364565079	1	1	0.999999737396233	0.999999737396233	1
up	F2; PF4; PRKCB; LCK; GP1BA; LYN; PF4V1; GP9; F2R; CD40; PTPN6; CD40LG; FCER1G; GP5; P2RX1; GNA12; PRKCD; TRPC3; DGKK; PIK3R6; BLOC1S3; PDPN; TREML1; PIK3R5; CLEC1B;	GO:0030168~platelet activation	25	102	24.5098039215686	0.0172336745330179	0.959691534896076	1	1	0.999999994869077	0.999999994869077	1
down	F12; KLK13; CPZ; CPXM2; CPXM1; CPE;	GO:0016485~protein processing	6	55	10.9090909090909	0.0174219706452924	0.130473520680912	1	1	0.999999737396233	0.999999737396233	1
up	MS4A1; ORAI1; ORAI3; STIM2; ORAI2;	GO:0002115~store-operated calcium entry	5	8	62.5	0.0177751565258045	0.959691534896076	1	1	0.999999994869077	0.999999994869077	1
up	CD160; HLA-E; HLA-G; HLA-F; KIR2DL4;	GO:0002729~positive regulation of natural killer cell cytokine production	5	8	62.5	0.0177751565258045	0.959691534896076	1	1	0.999999994869077	0.999999994869077	1
up	POU1F1; ZFAND2B; IGFBP4; IGFBP3; IGFBP5;	GO:0043567~regulation of insulin-like growth factor receptor signaling pathway	5	8	62.5	0.0177751565258045	0.959691534896076	1	1	0.999999994869077	0.999999994869077	1
down	CXCL10; PTN; EPHA2; EFNA3; ECSCR; IL17F; SPINK5; PLK2;	GO:0016525~negative regulation of angiogenesis	8	89	8.98876404494382	0.0177879630285266	0.132949078253051	1	1	0.999999737396233	0.999999737396233	1
down	SCGB1A1; PRLR; STC1; EMP2; DDR1;	GO:0007566~embryo implantation	5	40	12.5	0.0179817328916574	0.133864011526783	1	1	0.999999737396233	0.999999737396233	1
down	KRT8; KRT19; SYNPO2L; MYOZ1; TNNT2;	GO:0045214~sarcomere organization	5	40	12.5	0.0179817328916574	0.133864011526783	1	1	0.999999737396233	0.999999737396233	1
down	WNT9B; CTSV; KRT20; WNT4; CADPS2; WNT2B; MYH13;	GO:0009267~cellular response to starvation	7	72	9.72222222222222	0.0181001766153674	0.134345083717267	1	1	0.999999737396233	0.999999737396233	1
down	GJB3; GJB5; TRIP10; CCL19;	GO:0007154~cell communication	4	26	15.3846153846154	0.0181179670471581	0.134345083717267	1	1	0.999999737396233	0.999999737396233	1
down	WNT5A; GRHL3; TP63;	GO:0001736~establishment of planar polarity	3	14	21.4285714285714	0.0187341645485899	0.135459897935221	1	1	0.999999737396233	0.999999737396233	1
down	FUT3; B3GALT5; B3GALNT1;	GO:0009312~oligosaccharide biosynthetic process	3	14	21.4285714285714	0.0187341645485899	0.135459897935221	1	1	0.999999737396233	0.999999737396233	1
down	SFN; SLURP1; KDF1;	GO:0010839~negative regulation of keratinocyte proliferation	3	14	21.4285714285714	0.0187341645485899	0.135459897935221	1	1	0.999999737396233	0.999999737396233	1
down	FOXH1; ZNF366; TP63;	GO:0033147~negative regulation of intracellular estrogen receptor signaling pathway	3	14	21.4285714285714	0.0187341645485899	0.135459897935221	1	1	0.999999737396233	0.999999737396233	1
down	AKR1C1; CYP27C1; SDR16C5;	GO:0042574~retinal metabolic process	3	14	21.4285714285714	0.0187341645485899	0.135459897935221	1	1	0.999999737396233	0.999999737396233	1
down	EDN2; CX3CL1; CXCL17;	GO:0048246~macrophage chemotaxis	3	14	21.4285714285714	0.0187341645485899	0.135459897935221	1	1	0.999999737396233	0.999999737396233	1
down	AGR2; EPHB3; STRA6;	GO:0048546~digestive tract morphogenesis	3	14	21.4285714285714	0.0187341645485899	0.135459897935221	1	1	0.999999737396233	0.999999737396233	1
down	FOXP2; ITGA8; STRA6;	GO:0048745~smooth muscle tissue development	3	14	21.4285714285714	0.0187341645485899	0.135459897935221	1	1	0.999999737396233	0.999999737396233	1
down	GCNT3; ADRA2A; MOGAT2;	GO:0050892~intestinal absorption	3	14	21.4285714285714	0.0187341645485899	0.135459897935221	1	1	0.999999737396233	0.999999737396233	1
down	SCNN1A; SCNN1B; SCNN1G;	GO:0050909~sensory perception of taste	3	14	21.4285714285714	0.0187341645485899	0.135459897935221	1	1	0.999999737396233	0.999999737396233	1
down	ADRA2A; STC1; PACSIN3;	GO:0051926~negative regulation of calcium ion transport	3	14	21.4285714285714	0.0187341645485899	0.135459897935221	1	1	0.999999737396233	0.999999737396233	1
down	GJA1; TJP1; OCLN;	GO:2000810~regulation of bicellular tight junction assembly	3	14	21.4285714285714	0.0187341645485899	0.135459897935221	1	1	0.999999737396233	0.999999737396233	1
down	GPR37; CPE; ADCYAP1; NPY1R; NMU; TYRO3; QRFPR; GALR2; GPR1;	GO:0007218~neuropeptide signaling pathway	9	108	8.33333333333333	0.018751343169139	0.135459897935221	1	1	0.999999737396233	0.999999737396233	1
down	FUT1; FUT3; FUT6; FUT2; ST6GAL2; B3GNT6; B3GALNT1; B3GALT5;	GO:0006486~protein glycosylation	8	90	8.88888888888889	0.0188098632260795	0.135459897935221	1	1	0.999999737396233	0.999999737396233	1
down	SYCN; LGI3; SRCIN1; SYTL5; RAB25; CADPS2; EXOC3L2; STX19;	GO:0006887~exocytosis	8	90	8.88888888888889	0.0188098632260795	0.135459897935221	1	1	0.999999737396233	0.999999737396233	1
down	HRAS; ADRA2A; PLD1; DHCR24; PLK2; RERG; RASL12;	GO:0007265~Ras protein signal transduction	7	73	9.58904109589041	0.0192712885880977	0.138252150635837	1	1	0.999999737396233	0.999999737396233	1
up	IRF1; CTLA4; LAG3; MDK;	GO:0045590~negative regulation of regulatory T cell differentiation	4	5	80	0.0194706309047339	0.959691534896076	1	1	0.999999994869077	0.999999994869077	1
down	CRYAB; WNT5A; WNT2B; SLITRK6; CRYBA2;	GO:0002088~lens development in camera-type eye	5	41	12.1951219512195	0.0196246551776421	0.139984232369797	1	1	0.999999737396233	0.999999737396233	1
down	PLA2G10; PLA2G2A; PLD1; LIPI; PLA2G4D;	GO:0006654~phosphatidic acid biosynthetic process	5	41	12.1951219512195	0.0196246551776421	0.139984232369797	1	1	0.999999737396233	0.999999737396233	1
down	SLC7A2; SLC38A3; SLC6A15; SLC6A14; SLC25A48;	GO:0006865~amino acid transport	5	41	12.1951219512195	0.0196246551776421	0.139984232369797	1	1	0.999999737396233	0.999999737396233	1
down	TFAP2A; ITGA8; DLX5; USH1G; OTOP1; MYO6;	GO:0042472~inner ear morphogenesis	6	57	10.5263157894737	0.0201442313432864	0.141084760252868	1	1	0.999999737396233	0.999999737396233	1
down	HRAS; NME1; ID1; DLX5; EPGN; ESRP2;	GO:0050679~positive regulation of epithelial cell proliferation	6	57	10.5263157894737	0.0201442313432864	0.141084760252868	1	1	0.999999737396233	0.999999737396233	1
down	ADCYAP1; ADCYAP1R1; DEFB1; PCLO;	GO:0019933~cAMP-mediated signaling	4	27	14.8148148148148	0.0202549178438733	0.141084760252868	1	1	0.999999737396233	0.999999737396233	1
down	GLI2; CDH1; ADCYAP1; PITX1;	GO:0021983~pituitary gland development	4	27	14.8148148148148	0.0202549178438733	0.141084760252868	1	1	0.999999737396233	0.999999737396233	1
down	TJP1; WWC1; WWTR1; AMOTL2;	GO:0035329~hippo signaling	4	27	14.8148148148148	0.0202549178438733	0.141084760252868	1	1	0.999999737396233	0.999999737396233	1
down	HNF4A; IL18; ANGPTL8; ANGPTL4;	GO:0070328~triglyceride homeostasis	4	27	14.8148148148148	0.0202549178438733	0.141084760252868	1	1	0.999999737396233	0.999999737396233	1
down	DHCR24; DUOXA1; DUOXA2; PHYHIP; WNK4; SLC9A2; PARD3;	GO:0008104~protein localization	7	74	9.45945945945946	0.0204943473263259	0.141084760252868	1	1	0.999999737396233	0.999999737396233	1
down	CCL21; CXCL14; EPHA2; AGTR1; CX3CL1; ARHGEF16; DEFB4A;	GO:0060326~cell chemotaxis	7	74	9.45945945945946	0.0204943473263259	0.141084760252868	1	1	0.999999737396233	0.999999737396233	1
up	TYROBP; CTLA4; IL10; MNDA; CD300A; LYN; TNFRSF13B;	GO:0030889~negative regulation of B cell proliferation	7	16	43.75	0.020779568003743	0.959691534896076	1	1	0.999999994869077	0.999999994869077	1
up	FLOT1; TNF; THY1; LCK; ALOX15; IL10; SKAP1;	GO:0034116~positive regulation of heterotypic cell-cell adhesion	7	16	43.75	0.020779568003743	0.959691534896076	1	1	0.999999994869077	0.999999994869077	1
up	IRGM; HP; PPBP; ELANE; TNFRSF1A; IL10; GNLY; CAMP; IRF8; PRKCD; RBPJ; CEBPE; DEFB108B; MYD88; TLR9; IGHV6-1; IGLC3; IGHV1-46; IGHV3-13; TRBC1; IGHV1-2; TRBC2; IGHV3-30; IGLC2; IGLL5; IGHV2-5; IGHD; IGHV3-49; IGHV1-18; IGHV3-7; IGHE; IGHV4-34; IGHV5-51; IGHV3-35; IGHV3-23; FCER1G; HAMP; TRDC; IGHV3-43; IGKC; IGHV4-39; IGHV3-21; GSDMD; IGHV3-16; IGHV1-3;	GO:0042742~defense response to bacterium	45	216	20.8333333333333	0.021283887482094	0.959691534896076	1	1	0.999999994869077	0.999999994869077	1
down	CLDN4; RAMP2; PTN; GJB2; DSG1;	GO:0032570~response to progesterone	5	42	11.9047619047619	0.0213628967419009	0.141084760252868	1	1	0.999999737396233	0.999999737396233	1
down	FOXP2; CYP1A1; SHROOM2; HES5; STRA6;	GO:0043010~camera-type eye development	5	42	11.9047619047619	0.0213628967419009	0.141084760252868	1	1	0.999999737396233	0.999999737396233	1
down	FOXN1; TREH; HRAS; TH; BMP2; ELN; PHLDA2; LAMB4; EGFLAM;	GO:0009887~animal organ morphogenesis	9	111	8.10810810810811	0.021723351411712	0.141084760252868	1	1	0.999999737396233	0.999999737396233	1
down	STRA6; ROBO2; HEY2;	GO:0003184~pulmonary valve morphogenesis	3	15	20	0.0219222855083747	0.141084760252868	1	1	0.999999737396233	0.999999737396233	1
down	GGT5; GGT6; CHAC1;	GO:0006750~glutathione biosynthetic process	3	15	20	0.0219222855083747	0.141084760252868	1	1	0.999999737396233	0.999999737396233	1
down	SLC6A15; SLC6A14; GABRQ;	GO:0006836~neurotransmitter transport	3	15	20	0.0219222855083747	0.141084760252868	1	1	0.999999737396233	0.999999737396233	1
down	SPINT2; CDH1; MUC21;	GO:0022408~negative regulation of cell-cell adhesion	3	15	20	0.0219222855083747	0.141084760252868	1	1	0.999999737396233	0.999999737396233	1
down	MUC4; MUC13; TFF1;	GO:0030277~maintenance of gastrointestinal epithelium	3	15	20	0.0219222855083747	0.141084760252868	1	1	0.999999737396233	0.999999737396233	1
down	KRT14; KRT16; KRT33B;	GO:0042633~hair cycle	3	15	20	0.0219222855083747	0.141084760252868	1	1	0.999999737396233	0.999999737396233	1
down	GFRA3; TFAP2B; TP63;	GO:0048485~sympathetic nervous system development	3	15	20	0.0219222855083747	0.141084760252868	1	1	0.999999737396233	0.999999737396233	1
down	TH; BMP7; FOXF2;	GO:0048596~embryonic camera-type eye morphogenesis	3	15	20	0.0219222855083747	0.141084760252868	1	1	0.999999737396233	0.999999737396233	1
down	TACSTD2; SERPINB5; HES5;	GO:0050678~regulation of epithelial cell proliferation	3	15	20	0.0219222855083747	0.141084760252868	1	1	0.999999737396233	0.999999737396233	1
down	CIDEA; FFAR4; LGR4;	GO:0050710~negative regulation of cytokine secretion	3	15	20	0.0219222855083747	0.141084760252868	1	1	0.999999737396233	0.999999737396233	1
down	FOXA1; FOXF1; ESRP2;	GO:0060441~epithelial tube branching involved in lung morphogenesis	3	15	20	0.0219222855083747	0.141084760252868	1	1	0.999999737396233	0.999999737396233	1
down	BRINP1; SRPX2; MYH14;	GO:0071625~vocalization behavior	3	15	20	0.0219222855083747	0.141084760252868	1	1	0.999999737396233	0.999999737396233	1
down	PRDX1; UACA; TRIM6;	GO:1901222~regulation of NIK/NF-kappaB signaling	3	15	20	0.0219222855083747	0.141084760252868	1	1	0.999999737396233	0.999999737396233	1
down	ID1; KLF5; KLF15;	GO:1901653~cellular response to peptide	3	15	20	0.0219222855083747	0.141084760252868	1	1	0.999999737396233	0.999999737396233	1
down	ELN; EFNA1; ROBO2; HEY2;	GO:0003180~aortic valve morphogenesis	4	28	14.2857142857143	0.022540407391862	0.144074290518341	1	1	0.999999737396233	0.999999737396233	1
down	GPX3; PRDX1; DUOX2; DUOX1;	GO:0042744~hydrogen peroxide catabolic process	4	28	14.2857142857143	0.022540407391862	0.144074290518341	1	1	0.999999737396233	0.999999737396233	1
down	RAB38; ATP6V1C2; ATP6V0A4; SLAMF8;	GO:0090383~phagosome acidification	4	28	14.2857142857143	0.022540407391862	0.144074290518341	1	1	0.999999737396233	0.999999737396233	1
down	HRAS; MUC1; MUC3A; MUC21; CLEC10A; MUC20; MUC15; MUC4; MUC13;	GO:0002223~stimulatory C-type lectin receptor signaling pathway	9	112	8.03571428571429	0.0227850819846651	0.145390523140244	1	1	0.999999737396233	0.999999737396233	1
down	GJA1; WNT5A; ID4; DUOXA1; DUOXA2; FRMD6;	GO:0034613~cellular protein localization	6	59	10.1694915254237	0.0231414991371048	0.146915236484632	1	1	0.999999737396233	0.999999737396233	1
down	BMP7; ID4; IRX3; HES5; CNTN4; NOTCH3;	GO:0045665~negative regulation of neuron differentiation	6	59	10.1694915254237	0.0231414991371048	0.146915236484632	1	1	0.999999737396233	0.999999737396233	1
down	TF; BMP2; BMP7; HNF4A; ATOH8; INHA;	GO:0060395~SMAD protein signal transduction	6	59	10.1694915254237	0.0231414991371048	0.146915236484632	1	1	0.999999737396233	0.999999737396233	1
down	KCNK5; KCNJ5; KCNJ8; KCNJ18; SLC12A8;	GO:1990573~potassium ion import across plasma membrane	5	43	11.6279069767442	0.0231982677089752	0.147026858858234	1	1	0.999999737396233	0.999999737396233	1
down	SMIM22; GRHL3; FZD10; ARHGAP40; RND3; RHOD; RHOV;	GO:0032956~regulation of actin cytoskeleton organization	7	77	9.09090909090909	0.0244853137650834	0.154661443176083	1	1	0.999999737396233	0.999999737396233	1
down	NKX2-8; KRT4; PTN; WNT5A; CDKN2B; A4GNT;	GO:0050680~negative regulation of epithelial cell proliferation	6	60	10	0.0247465309598455	0.155640411212671	1	1	0.999999737396233	0.999999737396233	1
up	FES; LYN; RAC2; STXBP2; UNC13D;	GO:0043304~regulation of mast cell degranulation	5	9	55.5555555555556	0.0248029527053253	0.959691534896076	1	1	0.999999994869077	0.999999994869077	1
up	IGHD; ORM1; ORM2; PANX3; HMGB1P1;	GO:0050716~positive regulation of interleukin-1 secretion	5	9	55.5555555555556	0.0248029527053253	0.959691534896076	1	1	0.999999994869077	0.999999994869077	1
down	GALR2; NPY1R; MRAP2; STRA6;	GO:0007631~feeding behavior	4	29	13.7931034482759	0.0249766022972684	0.155640411212671	1	1	0.999999737396233	0.999999737396233	1
down	IL33; SCGB1A1; IL20RB; PGLYRP3;	GO:0032689~negative regulation of interferon-gamma production	4	29	13.7931034482759	0.0249766022972684	0.155640411212671	1	1	0.999999737396233	0.999999737396233	1
down	ADRA2C; COMT; MGLL; TMEM100;	GO:0051930~regulation of sensory perception of pain	4	29	13.7931034482759	0.0249766022972684	0.155640411212671	1	1	0.999999737396233	0.999999737396233	1
up	NCR3; SH2D1A; IL18RAP; CRTAM; CD160; HLA-E; LAG3; IL21;	GO:0045954~positive regulation of natural killer cell mediated cytotoxicity	8	21	38.0952380952381	0.0249958326280686	0.959691534896076	1	1	0.999999994869077	0.999999994869077	1
down	FOXH1; CCM2L; HEY2;	GO:0003222~ventricular trabecula myocardium morphogenesis	3	16	18.75	0.0253869753897	0.155640411212671	1	1	0.999999737396233	0.999999737396233	1
down	CYP2E1; MGST1; CCND1;	GO:0010243~response to organonitrogen compound	3	16	18.75	0.0253869753897	0.155640411212671	1	1	0.999999737396233	0.999999737396233	1
down	CCL21; S100A7; WNT5A;	GO:0010820~positive regulation of T cell chemotaxis	3	16	18.75	0.0253869753897	0.155640411212671	1	1	0.999999737396233	0.999999737396233	1
down	CYB5R2; CH25H; TM7SF2;	GO:0016126~sterol biosynthetic process	3	16	18.75	0.0253869753897	0.155640411212671	1	1	0.999999737396233	0.999999737396233	1
down	AQP1; RHOD; RND3;	GO:0030950~establishment or maintenance of actin cytoskeleton polarity	3	16	18.75	0.0253869753897	0.155640411212671	1	1	0.999999737396233	0.999999737396233	1
down	GPC1; WNT5A; WNT4;	GO:0040037~negative regulation of fibroblast growth factor receptor signaling pathway	3	16	18.75	0.0253869753897	0.155640411212671	1	1	0.999999737396233	0.999999737396233	1
down	INHA; BMP7; CDKN2B;	GO:0042326~negative regulation of phosphorylation	3	16	18.75	0.0253869753897	0.155640411212671	1	1	0.999999737396233	0.999999737396233	1
down	MMP7; PTN; ANXA1;	GO:0044849~estrous cycle	3	16	18.75	0.0253869753897	0.155640411212671	1	1	0.999999737396233	0.999999737396233	1
down	WNT5A; KLK6; KLK5;	GO:0045745~positive regulation of G protein-coupled receptor signaling pathway	3	16	18.75	0.0253869753897	0.155640411212671	1	1	0.999999737396233	0.999999737396233	1
down	GLI2; FOXF2; STRA6;	GO:0048566~embryonic digestive tract development	3	16	18.75	0.0253869753897	0.155640411212671	1	1	0.999999737396233	0.999999737396233	1
down	CDC20; RAB17; MARK1;	GO:0050773~regulation of dendrite development	3	16	18.75	0.0253869753897	0.155640411212671	1	1	0.999999737396233	0.999999737396233	1
down	PRLR; CCND1; DDR1;	GO:0060749~mammary gland alveolus development	3	16	18.75	0.0253869753897	0.155640411212671	1	1	0.999999737396233	0.999999737396233	1
down	ROBO4; CNTN4; IGSF9;	GO:0070593~dendrite self-avoidance	3	16	18.75	0.0253869753897	0.155640411212671	1	1	0.999999737396233	0.999999737396233	1
down	MIF; MUC1; ELL3;	GO:1902166~negative regulation of intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator	3	16	18.75	0.0253869753897	0.155640411212671	1	1	0.999999737396233	0.999999737396233	1
down	NKX2-8; S100B; CCK; PTPRZ1; CNTN4; PARD3; SLITRK6;	GO:0007409~axonogenesis	7	78	8.97435897435897	0.025926112937778	0.158686420460919	1	1	0.999999737396233	0.999999737396233	1
up	FCN1; TNF; CD2; CD14; F2R; CD244; PYCARD;	GO:2000484~positive regulation of interleukin-8 secretion	7	17	41.1764705882353	0.0261903037517568	0.959691534896076	1	1	0.999999994869077	0.999999994869077	1
down	PHGDH; GALR2; CDH1; ADCYAP1; ADGRF1; CNTN4; NRTN; FLRT3; CAMSAP3;	GO:0031175~neuron projection development	9	115	7.82608695652174	0.0261920028985423	0.160052760383275	1	1	0.999999737396233	0.999999737396233	1
up	SOCS1; PIAS1; IFNG; IFNGR1; PTPN2; IFNGR2;	GO:0060334~regulation of interferon-gamma-mediated signaling pathway	6	13	46.1538461538462	0.0264386019618894	0.959691534896076	1	1	0.999999994869077	0.999999994869077	1
down	PLA2G10; LRAT; KLF5; INA; BSPRY; ABCG4; SOX17; SHMT1;	GO:1990830~cellular response to leukemia inhibitory factor	8	97	8.24742268041237	0.0271614515784996	0.161784218934445	1	1	0.999999737396233	0.999999737396233	1
down	CEACAM1; AKR1C1; SLCO2B1; SLC10A6;	GO:0015721~bile acid and bile salt transport	4	30	13.3333333333333	0.0275653235125189	0.161784218934445	1	1	0.999999737396233	0.999999737396233	1
up	IFNG; HLA-G; CD40; CD40LG; CCR7; IRF8; IRF5; SCIMP; TLR9;	GO:0032735~positive regulation of interleukin-12 production	9	26	34.6153846153846	0.0279824774481862	0.959691534896076	1	1	0.999999994869077	0.999999994869077	1
down	GCAT; GGT5; PHGDH;	GO:0006520~cellular amino acid metabolic process	3	17	17.6470588235294	0.0291276149138606	0.1658373462167	1	1	0.999999737396233	0.999999737396233	1
down	WNT5A; FOXF1; CAMSAP3;	GO:0045198~establishment of epithelial cell apical/basal polarity	3	17	17.6470588235294	0.0291276149138606	0.1658373462167	1	1	0.999999737396233	0.999999737396233	1
down	GJA1; EPHA2; LGR4;	GO:0046849~bone remodeling	3	17	17.6470588235294	0.0291276149138606	0.1658373462167	1	1	0.999999737396233	0.999999737396233	1
up	TNF; APOA2; IL10; LILRB1;	GO:0002740~negative regulation of cytokine secretion involved in immune response	4	6	66.6666666666667	0.0292275219946413	0.959691534896076	1	1	0.999999994869077	0.999999994869077	1
up	HLA-B; HLA-A; HLA-E; HLA-G;	GO:0042270~protection from natural killer cell mediated cytotoxicity	4	6	66.6666666666667	0.0292275219946413	0.959691534896076	1	1	0.999999994869077	0.999999994869077	1
up	LYN; SPI1; B2M; P4HTM;	GO:0045646~regulation of erythrocyte differentiation	4	6	66.6666666666667	0.0292275219946413	0.959691534896076	1	1	0.999999994869077	0.999999994869077	1
up	HLA-G; TMEM176B; LILRB1; TMEM176A;	GO:2001199~negative regulation of dendritic cell differentiation	4	6	66.6666666666667	0.0292275219946413	0.959691534896076	1	1	0.999999994869077	0.999999994869077	1
down	NME1; PRLR; CCND1; XDH; DDR1;	GO:0007595~lactation	5	46	10.8695652173913	0.0293032624160288	0.166584606946879	1	1	0.999999737396233	0.999999737396233	1
down	MARK1; CAMSAP3; PARD3; TACC2; TUBB6; TUBG1; TUBAL3; CALML3; CALML5;	GO:0000226~microtubule cytoskeleton organization	9	118	7.6271186440678	0.029943705613838	0.169967902364781	1	1	0.999999737396233	0.999999737396233	1
down	WNT9A; HRAS; CDKN2B; PLK2;	GO:0007093~mitotic cell cycle checkpoint	4	31	12.9032258064516	0.0303080520765303	0.170744461548261	1	1	0.999999737396233	0.999999737396233	1
down	KRT14; TH; CPS1; GGH;	GO:0010043~response to zinc ion	4	31	12.9032258064516	0.0303080520765303	0.170744461548261	1	1	0.999999737396233	0.999999737396233	1
down	SLPI; CTSG; DEFB1; RNASE7;	GO:0019731~antibacterial humoral response	4	31	12.9032258064516	0.0303080520765303	0.170744461548261	1	1	0.999999737396233	0.999999737396233	1
down	CCL21; FGFR3; TNFAIP8L3; CCL19;	GO:0043552~positive regulation of phosphatidylinositol 3-kinase activity	4	31	12.9032258064516	0.0303080520765303	0.170744461548261	1	1	0.999999737396233	0.999999737396233	1
down	HOXC6; WNT5A; HOXC5; KIAA1217;	GO:0048706~embryonic skeletal system development	4	31	12.9032258064516	0.0303080520765303	0.170744461548261	1	1	0.999999737396233	0.999999737396233	1
up	NCR3; NCR1; IFNB1; ITGB2; CD2; IL2; IL21R; SLAMF7;	GO:0030101~natural killer cell activation	8	22	36.3636363636364	0.0303870129731134	0.959691534896076	1	1	0.999999994869077	0.999999994869077	1
up	IFNG; CD4; HLA-DRB1; CSF1R; SPI1; CEBPE; IL31RA; EIF2AK1;	GO:0030225~macrophage differentiation	8	22	36.3636363636364	0.0303870129731134	0.959691534896076	1	1	0.999999994869077	0.999999994869077	1
up	AKT1; NUP62; FASLG; PLAUR; SHKBP1; DOK1; PDE6H; PDE6G;	GO:0045742~positive regulation of epidermal growth factor receptor signaling pathway	8	22	36.3636363636364	0.0303870129731134	0.959691534896076	1	1	0.999999994869077	0.999999994869077	1
up	LILRA5; IFNG; ORM1; LPL; IFNGR1; ORM2; MMP8; LILRA2;	GO:1904469~positive regulation of tumor necrosis factor secretion	8	22	36.3636363636364	0.0303870129731134	0.959691534896076	1	1	0.999999994869077	0.999999994869077	1
up	HLA-G; LILRB2; LILRB1;	GO:0002767~immune response-inhibiting cell surface receptor signaling pathway	3	3	100	0.0306351411116277	0.959691534896076	1	1	0.999999994869077	0.999999994869077	1
up	LYN; LILRB2; LILRB1;	GO:0002774~Fc receptor mediated inhibitory signaling pathway	3	3	100	0.0306351411116277	0.959691534896076	1	1	0.999999994869077	0.999999994869077	1
up	SAT2; SAT1; SATL1;	GO:0032918~spermidine acetylation	3	3	100	0.0306351411116277	0.959691534896076	1	1	0.999999994869077	0.999999994869077	1
up	ADA; DPP4; FERMT3;	GO:0033632~regulation of cell-cell adhesion mediated by integrin	3	3	100	0.0306351411116277	0.959691534896076	1	1	0.999999994869077	0.999999994869077	1
up	HLA-A; HLA-E; CLEC4A;	GO:0036037~CD8-positive, alpha-beta T cell activation	3	3	100	0.0306351411116277	0.959691534896076	1	1	0.999999994869077	0.999999994869077	1
up	CD4; CD74; CD1D;	GO:0045058~T cell selection	3	3	100	0.0306351411116277	0.959691534896076	1	1	0.999999994869077	0.999999994869077	1
up	TUSC2; F2; ELANE;	GO:0070945~neutrophil-mediated killing of gram-negative bacterium	3	3	100	0.0306351411116277	0.959691534896076	1	1	0.999999994869077	0.999999994869077	1
up	LCK; MDK; SKAP1;	GO:1903039~positive regulation of leukocyte cell-cell adhesion	3	3	100	0.0306351411116277	0.959691534896076	1	1	0.999999994869077	0.999999994869077	1
up	LILRA5; LILRB1; TLR8;	GO:2001183~negative regulation of interleukin-12 secretion	3	3	100	0.0306351411116277	0.959691534896076	1	1	0.999999994869077	0.999999994869077	1
down	FGF1; PTN; BTC; GAREM1; GKN1;	GO:0051781~positive regulation of cell division	5	47	10.6382978723404	0.0315425781809466	0.177432913545595	1	1	0.999999737396233	0.999999737396233	1
up	SH2B2; F13A1; F2; F10; PLG; SERPINA1; IFNA21; IFNA5; IFNB1; F11; GP1BA; LYN; TFPI; IRF1; F3; IRF2; GP9; GATA1; GATA3; F2R; FCER1G; GP5; P2RX1; HBG1; HBG2; GNA12; PLAUR; NFE2; HPS6; SCUBE1; DTNBP1; P2RX4; VKORC1; EHD1; HMG20B; SERPINA10;	GO:0007596~blood coagulation	36	171	21.0526315789474	0.0321576919866359	0.959691534896076	1	1	0.999999994869077	0.999999994869077	1
up	SPI1; RELB; RBPJ; IRF4; BATF; DCSTAMP; BATF3;	GO:0043011~myeloid dendritic cell differentiation	7	18	38.8888888888889	0.032486205947021	0.959691534896076	1	1	0.999999994869077	0.999999994869077	1
down	C1QA; TFF1; CCND1;	GO:0010039~response to iron ion	3	18	16.6666666666667	0.0331425628353996	0.184496877979851	1	1	0.999999737396233	0.999999737396233	1
down	TRPV6; SYT8; SYT7;	GO:0017158~regulation of calcium ion-dependent exocytosis	3	18	16.6666666666667	0.0331425628353996	0.184496877979851	1	1	0.999999737396233	0.999999737396233	1
down	GLI2; BMP7; HNF1B;	GO:0030902~hindbrain development	3	18	16.6666666666667	0.0331425628353996	0.184496877979851	1	1	0.999999737396233	0.999999737396233	1
down	EDN2; NPNT; NMU;	GO:0045987~positive regulation of smooth muscle contraction	3	18	16.6666666666667	0.0331425628353996	0.184496877979851	1	1	0.999999737396233	0.999999737396233	1
down	HNF1B; FOXF1; OVOL2;	GO:0048557~embryonic digestive tract morphogenesis	3	18	16.6666666666667	0.0331425628353996	0.184496877979851	1	1	0.999999737396233	0.999999737396233	1
down	SOX18; MARVELD2; ROBO4;	GO:0061028~establishment of endothelial barrier	3	18	16.6666666666667	0.0331425628353996	0.184496877979851	1	1	0.999999737396233	0.999999737396233	1
down	FGF1; FUT1; TJP1;	GO:1903672~positive regulation of sprouting angiogenesis	3	18	16.6666666666667	0.0331425628353996	0.184496877979851	1	1	0.999999737396233	0.999999737396233	1
down	DKK1; BMP7; WNT3; MESP2;	GO:0001707~mesoderm formation	4	32	12.5	0.0332059359313328	0.184575809799053	1	1	0.999999737396233	0.999999737396233	1
up	LAMTOR5; APOL3; TNF; CD4; HLA-DRB1; CD74; PRKCB; RHOC; TNFRSF1A; F2R; CD40; S100A4; CASP1; CCR7; NUP62; FASLG; TNFSF10; BST2; IKBKE; IRF3; PRKD1; TRADD; CARD16; CLEC6A; SHISA5; TNIP2; SLC35B2; C18orf32; SECTM1; TMEM106A; LITAF; MYD88; RBCK1; SHARPIN; CARD9; TLR9; TERF2IP; PIM2;	GO:0043123~positive regulation of I-kappaB kinase/NF-kappaB signaling	38	183	20.7650273224044	0.0332105385531769	0.959691534896076	1	1	0.999999994869077	0.999999994869077	1
up	ZG16; IL18RAP; EOMES; AVPR2; LILRB1;	GO:0032609~interferon-gamma production	5	10	50	0.0333892297275032	0.959691534896076	1	1	0.999999994869077	0.999999994869077	1
up	IFNG; XBP1; AZU1; IL10; TMEM106A;	GO:0045348~positive regulation of MHC class II biosynthetic process	5	10	50	0.0333892297275032	0.959691534896076	1	1	0.999999994869077	0.999999994869077	1
up	CD4; HLA-DRB1; CD74; TRIM21; TRIM11;	GO:0046598~positive regulation of viral entry into host cell	5	10	50	0.0333892297275032	0.959691534896076	1	1	0.999999994869077	0.999999994869077	1
up	HBQ1; HBG1; HBG2; HBA1; HBM; CYGB;	GO:0015671~oxygen transport	6	14	42.8571428571429	0.0338041837860295	0.959691534896076	1	1	0.999999994869077	0.999999994869077	1
up	CD276; IL27; IL21; TLR9; TLR8; TLR7;	GO:0045078~positive regulation of interferon-gamma biosynthetic process	6	14	42.8571428571429	0.0338041837860295	0.959691534896076	1	1	0.999999994869077	0.999999994869077	1
up	PTH; CD33; CAV3; LILRB2; LILRB1; INPP5K;	GO:0051926~negative regulation of calcium ion transport	6	14	42.8571428571429	0.0338041837860295	0.959691534896076	1	1	0.999999994869077	0.999999994869077	1
down	APOD; VLDLR; ABCA12; SPNS2; SLCO2A1; STARD10;	GO:0006869~lipid transport	6	65	9.23076923076923	0.0338817188570586	0.185813402071016	1	1	0.999999737396233	0.999999737396233	1
down	GLI2; FOXF1; NSDHL; HES5; TMEM17; BOC;	GO:0007224~smoothened signaling pathway	6	65	9.23076923076923	0.0338817188570586	0.185813402071016	1	1	0.999999737396233	0.999999737396233	1
down	MIF; CCNB1; AQP1; BTC; WNT5A;	GO:0048146~positive regulation of fibroblast proliferation	5	48	10.4166666666667	0.0338860543965945	0.185813402071016	1	1	0.999999737396233	0.999999737396233	1
down	FGF1; GHR; BMP2; NTF3; WNT5A; EPGN; CXCL17; LPAR3; MUC20;	GO:0000187~activation of MAPK activity	9	122	7.37704918032787	0.0355076316127507	0.185813402071016	1	1	0.999999737396233	0.999999737396233	1
down	WNT9B; TFAP2A; MEOX2; EPHB3; DLX5; FOXF2;	GO:0060021~roof of mouth development	6	66	9.09090909090909	0.0359377750323874	0.187536205732291	1	1	0.999999737396233	0.999999737396233	1
up	ADCY5; S1PR4; KNG1; OXT; CALCA; F2R; CD52; GLP1R; CAV3; IL2; C1QTNF1; PROK2; GPR35; TRPC5; PTGER4; PTGDR; CCR10; TBXA2R; FPR3; CMKLR1; CXCR3; CCR7; CCR8; PTGER2; CCR6; CCR5; CXCR5; PTGIR; CCR2; CCR3; C3AR1; CXCR1;	GO:0007204~positive regulation of cytosolic calcium ion concentration	32	150	21.3333333333333	0.0362325380723891	0.959691534896076	1	1	0.999999994869077	0.999999994869077	1
down	DLX3; DLX5; DLG2;	GO:0009790~embryo development	3	19	15.7894736842105	0.0374292514145782	0.193169946777851	1	1	0.999999737396233	0.999999737396233	1
down	MYO1A; MYO5C; MYO6;	GO:0030050~vesicle transport along actin filament	3	19	15.7894736842105	0.0374292514145782	0.193169946777851	1	1	0.999999737396233	0.999999737396233	1
down	WNT9B; DHCR24; LGR4;	GO:0030539~male genitalia development	3	19	15.7894736842105	0.0374292514145782	0.193169946777851	1	1	0.999999737396233	0.999999737396233	1
down	PTN; PTPRZ1; HES5;	GO:0031641~regulation of myelination	3	19	15.7894736842105	0.0374292514145782	0.193169946777851	1	1	0.999999737396233	0.999999737396233	1
down	CIDEA; CIDEC; HILPDA;	GO:0034389~lipid droplet organization	3	19	15.7894736842105	0.0374292514145782	0.193169946777851	1	1	0.999999737396233	0.999999737396233	1
down	EPHA2; WNT5A; TP63;	GO:0036342~post-anal tail morphogenesis	3	19	15.7894736842105	0.0374292514145782	0.193169946777851	1	1	0.999999737396233	0.999999737396233	1
down	ALDH1L1; FOLR1; SHMT1;	GO:0046655~folic acid metabolic process	3	19	15.7894736842105	0.0374292514145782	0.193169946777851	1	1	0.999999737396233	0.999999737396233	1
down	TULP1; RGS9BP; REEP6;	GO:0050908~detection of light stimulus involved in visual perception	3	19	15.7894736842105	0.0374292514145782	0.193169946777851	1	1	0.999999737396233	0.999999737396233	1
down	FAM83G; BMP2; BMP7; ID1; DLX5; SOSTDC1; TMEM100;	GO:0030509~BMP signaling pathway	7	85	8.23529411764706	0.0376467034628996	0.194025317847252	1	1	0.999999737396233	0.999999737396233	1
down	CTSV; GJA1; HNF1B; HNF4A; GYS2; NR0B2;	GO:0009749~response to glucose	6	67	8.95522388059701	0.0380721861452568	0.195949029378605	1	1	0.999999737396233	0.999999737396233	1
down	EI24; CRYAB; GJA1; HNF4A; BDKRB1; GNG4; FRZB; RERG; SOX17;	GO:0030308~negative regulation of cell growth	9	124	7.25806451612903	0.0385392571974789	0.198081223294439	1	1	0.999999737396233	0.999999737396233	1
down	PTN; CX3CL1; CNTN4; FGF14; PLK2;	GO:0048167~regulation of synaptic plasticity	5	50	10	0.0388893238297624	0.199607035580395	1	1	0.999999737396233	0.999999737396233	1
down	RBFOX2; VLDLR; PREX2; DCDC2;	GO:0048813~dendrite morphogenesis	4	34	11.7647058823529	0.0394701431618021	0.202311444184537	1	1	0.999999737396233	0.999999737396233	1
up	CD160; CCL2; HLA-G; CD40; CD40LG; FASLG; RGCC;	GO:2000353~positive regulation of endothelial cell apoptotic process	7	19	36.8421052631579	0.0397156746198305	0.959691534896076	1	1	0.999999994869077	0.999999994869077	1
down	TACSTD2; SCNN1A; SCNN1B; SCNN1G; IRX5; MYO3A;	GO:0050896~response to stimulus	6	68	8.82352941176471	0.0402856741889788	0.206209890255182	1	1	0.999999737396233	0.999999737396233	1
up	BPI; CD33; IL10; TLR9;	GO:0032717~negative regulation of interleukin-8 production	4	7	57.1428571428571	0.0413912753082321	0.959691534896076	1	1	0.999999994869077	0.999999994869077	1
up	LPXN; GPS2; FCRL3; CD300A;	GO:0050859~negative regulation of B cell receptor signaling pathway	4	7	57.1428571428571	0.0413912753082321	0.959691534896076	1	1	0.999999994869077	0.999999994869077	1
down	TH; NPY1R; CHRNB4; SLURP1; NAV2; PAK6; PAK5;	GO:0007626~locomotory behavior	7	87	8.04597701149425	0.0415431059708644	0.210677136301075	1	1	0.999999737396233	0.999999737396233	1
down	EPCAM; HNF4A; SOX17;	GO:0023019~signal transduction involved in regulation of gene expression	3	20	15	0.0419842757242785	0.210677136301075	1	1	0.999999737396233	0.999999737396233	1
down	WNT5A; SEMA3F; ABHD17C;	GO:0099175~regulation of postsynapse organization	3	20	15	0.0419842757242785	0.210677136301075	1	1	0.999999737396233	0.999999737396233	1
down	DDR1; PAK6; FLRT3;	GO:1990138~neuron projection extension	3	20	15	0.0419842757242785	0.210677136301075	1	1	0.999999737396233	0.999999737396233	1
up	IFNG; IL2RA; CTLA4; IL2; FOXP3; TNFRSF18;	GO:0045589~regulation of regulatory T cell differentiation	6	15	40	0.0423746646586783	0.959691534896076	1	1	0.999999994869077	0.999999994869077	1
up	PPP1R11; PTGER4; BTN2A2; FOXP3; RGCC; TNFRSF4;	GO:0050710~negative regulation of cytokine secretion	6	15	40	0.0423746646586783	0.959691534896076	1	1	0.999999994869077	0.999999994869077	1
down	GHR; FGFR3; PTK6; IL18; HES5; STAP2;	GO:0042531~positive regulation of tyrosine phosphorylation of STAT protein	6	69	8.69565217391304	0.0425788889333361	0.210677136301075	1	1	0.999999737396233	0.999999737396233	1
down	DEFB4A; LCE3A; PGLYRP4; PGLYRP3;	GO:0031640~killing of cells of other organism	4	35	11.4285714285714	0.0428371707322079	0.210677136301075	1	1	0.999999737396233	0.999999737396233	1
down	PTPN3; BTC; EPGN; CBLC;	GO:0042059~negative regulation of epidermal growth factor receptor signaling pathway	4	35	11.4285714285714	0.0428371707322079	0.210677136301075	1	1	0.999999737396233	0.999999737396233	1
down	EDN2; NMU; IRX3; MRAP2;	GO:0097009~energy homeostasis	4	35	11.4285714285714	0.0428371707322079	0.210677136301075	1	1	0.999999737396233	0.999999737396233	1
up	IFITM1; TRIM21; SP100; CD40; IFITM2; BST2; CXCL16; NUB1;	GO:0034341~response to interferon-gamma	8	24	33.3333333333333	0.0434414210225376	0.959691534896076	1	1	0.999999994869077	0.999999994869077	1
up	CRTAM; HLA-A; CTSH; PRF1; GZMM;	GO:0001913~T cell mediated cytotoxicity	5	11	45.4545454545455	0.0436070970863152	0.959691534896076	1	1	0.999999994869077	0.999999994869077	1
up	ITGB2; ELANE; CCR6; ADAM8; FUT7;	GO:0002523~leukocyte migration involved in inflammatory response	5	11	45.4545454545455	0.0436070970863152	0.959691534896076	1	1	0.999999994869077	0.999999994869077	1
up	HLA-B; HLA-DRB1; HLA-A; CD1D; PGLYRP2;	GO:0016045~detection of bacterium	5	11	45.4545454545455	0.0436070970863152	0.959691534896076	1	1	0.999999994869077	0.999999994869077	1
up	IFITM1; IFNAR2; IFITM2; BST2; IKBKE;	GO:0035456~response to interferon-beta	5	11	45.4545454545455	0.0436070970863152	0.959691534896076	1	1	0.999999994869077	0.999999994869077	1
up	TK2; TYMP; DCK; PUDP; UCK1;	GO:0043097~pyrimidine nucleoside salvage	5	11	45.4545454545455	0.0436070970863152	0.959691534896076	1	1	0.999999994869077	0.999999994869077	1
up	CD4; HLA-DRB1; CD74; FES; DCSTAMP;	GO:0045657~positive regulation of monocyte differentiation	5	11	45.4545454545455	0.0436070970863152	0.959691534896076	1	1	0.999999994869077	0.999999994869077	1
down	NFASC; PIGR; SLPI; CSTB; CTSG; MGST1; CEACAM1; MIF; JUP; DSP; TCN1; SERPINB3; CHRNB4; S100A7; PRSS3; CEACAM6; CRISP3; LCN2; DSG1; PLD1; PKP1; FLG2; GGH; SERPINB12; CALML5;	GO:0043312~neutrophil degranulation	25	483	5.175983436853	0.0440584397799002	0.213299698134433	1	1	0.999999737396233	0.999999737396233	1
up	TAPBP; HLA-B; HLA-H; HLA-A; HLA-E; HLA-G; HLA-F; B2M; TAP1;	GO:0002474~antigen processing and presentation of peptide antigen via MHC class I	9	29	31.0344827586207	0.0456451271506705	0.959691534896076	1	1	0.999999994869077	0.999999994869077	1
up	VIL1; HCLS1; AIF1; CORO7; ARPC4; LMOD2; CATIP; MSRB1; MSRB2;	GO:0030041~actin filament polymerization	9	29	31.0344827586207	0.0456451271506705	0.959691534896076	1	1	0.999999994869077	0.999999994869077	1
down	WNT9A; EDN3; BTC; SOX17;	GO:0045597~positive regulation of cell differentiation	4	36	11.1111111111111	0.0463607811373735	0.216259820438344	1	1	0.999999737396233	0.999999737396233	1
down	WNT9A; FOXA1; TTC23; DCDC2;	GO:0045880~positive regulation of smoothened signaling pathway	4	36	11.1111111111111	0.0463607811373735	0.216259820438344	1	1	0.999999737396233	0.999999737396233	1
down	KDR; CLEC14A; MMRN2;	GO:0002042~cell migration involved in sprouting angiogenesis	3	21	14.2857142857143	0.0468034771288218	0.216259820438344	1	1	0.999999737396233	0.999999737396233	1
down	PLPP2; FUT3; FUT6;	GO:0006672~ceramide metabolic process	3	21	14.2857142857143	0.0468034771288218	0.216259820438344	1	1	0.999999737396233	0.999999737396233	1
down	TCN1; PRSS3; AMN;	GO:0009235~cobalamin metabolic process	3	21	14.2857142857143	0.0468034771288218	0.216259820438344	1	1	0.999999737396233	0.999999737396233	1
down	SCEL; CAMSAP3; STOX2;	GO:0009792~embryo development ending in birth or egg hatching	3	21	14.2857142857143	0.0468034771288218	0.216259820438344	1	1	0.999999737396233	0.999999737396233	1
down	CYP1A1; CPS1; HSD11B2;	GO:0032094~response to food	3	21	14.2857142857143	0.0468034771288218	0.216259820438344	1	1	0.999999737396233	0.999999737396233	1
down	WNT5A; FRZB; FZD10;	GO:0035567~non-canonical Wnt signaling pathway	3	21	14.2857142857143	0.0468034771288218	0.216259820438344	1	1	0.999999737396233	0.999999737396233	1
down	NSDHL; OVOL2; HEY2;	GO:0060716~labyrinthine layer blood vessel development	3	21	14.2857142857143	0.0468034771288218	0.216259820438344	1	1	0.999999737396233	0.999999737396233	1
down	FOXH1; FOXF1; IL1F10; IL1RL2; CRNN;	GO:0071345~cellular response to cytokine stimulus	5	53	9.43396226415094	0.0471957785594908	0.216259820438344	1	1	0.999999737396233	0.999999737396233	1
down	RAMP3; AGR2; EPHA2; PLS1; ARHGEF16;	GO:1903078~positive regulation of protein localization to plasma membrane	5	53	9.43396226415094	0.0471957785594908	0.216259820438344	1	1	0.999999737396233	0.999999737396233	1
down	CDH1; NQO1; CYP2F1; SLC6A1; SLC6A14; PON3;	GO:0009636~response to toxic substance	6	71	8.45070422535211	0.0474067336860711	0.216259820438344	1	1	0.999999737396233	0.999999737396233	1
down	SOX15; INHA; WNT5A; STAR; WNT4; TFAP2C; WNT2B;	GO:0008584~male gonad development	7	90	7.77777777777778	0.0478622602425083	0.216259820438344	1	1	0.999999737396233	0.999999737396233	1
up	FXYD1; CAV3; YWHAH; RANGRF; FXYD6; FXYD5; FXYD2;	GO:2000649~regulation of sodium ion transmembrane transporter activity	7	20	35	0.0479175056838046	0.959691534896076	1	1	0.999999994869077	0.999999994869077	1
up	HLA-B; CLC; FOXP3;	GO:0002667~regulation of T cell anergy	3	4	75	0.0486023082377168	0.959691534896076	1	1	0.999999994869077	0.999999994869077	1
up	TNFRSF1B; CCR2; CLC;	GO:0002724~regulation of T cell cytokine production	3	4	75	0.0486023082377168	0.959691534896076	1	1	0.999999994869077	0.999999994869077	1
up	TNFRSF1A; TNFRSF1B; RBPJ;	GO:0003176~aortic valve development	3	4	75	0.0486023082377168	0.959691534896076	1	1	0.999999994869077	0.999999994869077	1
up	TNFRSF1A; TNFRSF1B; RBPJ;	GO:0003177~pulmonary valve development	3	4	75	0.0486023082377168	0.959691534896076	1	1	0.999999994869077	0.999999994869077	1
up	F10; TFPI; F3;	GO:0007598~blood coagulation, extrinsic pathway	3	4	75	0.0486023082377168	0.959691534896076	1	1	0.999999994869077	0.999999994869077	1
up	HLA-A; CLEC4A; FCER1G;	GO:0042590~antigen processing and presentation of exogenous peptide antigen via MHC class I	3	4	75	0.0486023082377168	0.959691534896076	1	1	0.999999994869077	0.999999994869077	1
up	TLR9; TLR8; TLR7;	GO:0045356~positive regulation of interferon-alpha biosynthetic process	3	4	75	0.0486023082377168	0.959691534896076	1	1	0.999999994869077	0.999999994869077	1
up	GATA3; CCR6; TBX21;	GO:0072676~lymphocyte migration	3	4	75	0.0486023082377168	0.959691534896076	1	1	0.999999994869077	0.999999994869077	1
up	HLA-A; HLA-E; XCL1;	GO:2000566~positive regulation of CD8-positive, alpha-beta T cell proliferation	3	4	75	0.0486023082377168	0.959691534896076	1	1	0.999999994869077	0.999999994869077	1
down	WNT9A; CRYAB; AQP1; SFN; DHCR24; TFAP2B;	GO:0043154~negative regulation of cysteine-type endopeptidase activity involved in apoptotic process	6	72	8.33333333333333	0.0499422984414462	0.216259820438344	1	1	0.999999737396233	0.999999737396233	1
